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ABSTRACT 
ROLE OF MSA IN IMMUNE EVASION, PERSISTENCE AND PROTEASE  
REGULATION IN THE HUMAN PATHOGENIC STRAINS OF  
STAPHYLOCOCCUS AUREUS 
by Maria Deepa Shanthini Basco 
August 2013 
Opportunistic pathogens like Staphylococcus aureus on entering the host can stay 
colonized at the foci of infection or evade the immune system to disseminate to other 
sites. In this study we investigated the regulatory influence of the modulator of sarA 
(msa) on immune evasion and host persistence, employing the hospital-acquired strain S. 
aureus UAMS-1 and community-acquired strain S. aureus USA300 LAC. In the murine 
sepsis model, mutation of the msa gene in LAC showed no change in dissemination of 
infection; however, in UAMS-1 a decrease in microbial load was observed in the lungs. 
Differential regulation by the msa gene was also observed in the blood survival and 
neutrophil assays. Several evasion factors were found to be regulated by msa, namely the 
scn, clfA, spa, aur, and sak genes. Interestingly, the combination of factors and the 
regulation of these factors differed in the two strains. 
S. aureus form biofilms on post-surgical wounds, prosthetic devices, and various 
host tissues that are resilient to immunological clearance and antimicrobial treatments. 
Biofilm detachment is a stage of biofilm development that aids in metastasis of infection. 
Proteases are one of the factors that trigger biofilm detachment. In our study, we 
observed msa to regulate proteases of S. aureus strain LAC when they are not in the form 
of a biofilm community; however, when they form biofilms the regulatory effect on 
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proteases by the msa gene is absent. Thus, we show the environment-dependent behavior 
of the msa gene.
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CHAPTER I 
INTRODUCTION 
Staphylococcus aureus 
Taxonomic Classification 
Domain: Bacteria 
Kingdom: Eubacteria 
Phylum: Firmicutes 
Class: Bacilli 
Order: Bacillales 
Family: Staphylococcaceae 
Genus: Staphylococcus 
Species: aureus 
Nomenclature 
Staphylococcus, discovered back in the 1880s by Alexander Ogston while 
studying the cause of pus-formation (Ogston, 1880), is currently one of the most 
successful gram positive pathogens. Ogston investigated stained smears obtained from an 
abscess under a microscope and observed chains and groups of spherical organisms. He 
conducted experiments with the pus obtained from abscesses on guinea pigs and mice, 
and confirmed the pus-forming abscesses were caused by the spherical organisms 
(Ogston, 1880). In 1881, Ogston published a report describing Staphylococcus (then 
referred to as Micrococcus) to cause septicemia as well (Ogston, 1881). In 1882, Ogston 
renamed the Micrococci as Staphylococci, deriving its prefix from the greek word 
staphyle which meant bunch of grapes. Owing to a golden pigmentation which was 
 2 
 
 
unique to a group of Staphylococci, Anton J. Rosenbach in 1884 named them 
Staphylococcus aureus (aurum in Latin meant golden) (Rosenbach, 1884) (Figure 1). 
 
Figure 1. Quadrant streak of Staphylococcus aureus colonies showing the typical golden 
yellow colonies (Hedetniemi & Liao, 2010). 
 
Staphylococci 
Staphylococci grow to an average diameter of 0.6–1.2 µm and are non-spore 
forming and non-motile. They are facultative anaerobes capable of growing in an aerobic 
and anaerobic environment. Staphylococci are highly adaptable microbes, capable of 
growing in a pH range of 5 to 9. They are also resistant to desiccation and high salt 
concentrations (Graham & Wilkinson, 1992).  
 
Figure 2. Gram staining of Staphylococcus aureus showing grape-like clusters of 
staphylococcal cells (Wistreich, 2011). 
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The genus of Staphylococcus contains mostly pathogens. S. epidermidis, S. 
saprophyticus, S. lugdunensis, S. haemolyticus, S. warneri, S. schleiferi, and S. 
intermedius are some of pathogenic members of this genus. Based on the ability to 
produce coagulase, bacteria belonging to the genus Staphylococcus are differentiated into 
coagulase-positive and coagulase-negative staphylococci. S. aureus is one of the major 
pathogens that belong to the coagulase-positive staphylococci. Coagulase-negative 
staphylococcus has several pathologically relevant members like S. epidermidis, S. 
saprophyticus, S. haemolyticus, and S. sciuri.  
S. aureus is commonly found in mammals as part of their normal flora. It is found 
usually in the nasal passages, axillae, skin, mouth, and along the gastrointestinal and 
vaginal tract (Smith, Noble, Bensch, Ahlin, Jacobson, & Latham, 1982; Williams, 1946, 
1963). According to a study conducted by Peacock and colleagues in 2001, 20% of the 
population was permanent and 60% were transient nasal carriers of S. aureus (Peacock, 
de Silva, & Lowy, 2001). Thus, human beings are good reservoirs of S. aureus. Only 
30% of the nasal colonization is permanent, leaving the majority to short-termed 
colonization (von Eiff, Machka, Stammer, & Peters, 2001). Different strains of S. aureus 
have varying preferential sites of colonization depending on the presence of colonization 
and adhesion factors. For instance, community acquired Methicillin Resistant S. aureus 
(CA-MRSA) preferentially colonize the skin and throat (Mertz et al., 2007). Colonization 
of S. aureus is very important to study, as it is important in the determination of the 
transmission of infections and possibly in the treatment regimens. 
S. aureus causes superficial skin infections like impetigo, cellulitis, folliculitis, 
and severe scalded skin syndrome. When S. aureus invades the blood stream, it causes 
bacteremia and infections of the organs in the path of the blood stream like endocarditis, 
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osteomyelitis, and septic arthritis. Staphylococcal pneumonia, otitis media, and 
meningitis are some of the other clinical manifestations of S. aureus infections. Owing to 
the variety of enterotoxins produced, S. aureus is also a major contaminant in the food 
industry. S. aureus causes staphylococcal food poisoning with characteristic symptoms of 
stomach pain and diarrhea. 
   
Figure 3. Some of the infections caused by S. aureus: (A) a cutaneous abscess
1
 of S. 
aureus (Morgan, 2010), (B) an osteomyelitis infection caused by S. aureus (Antimicrobe, 
2010) and (C) an infection of a of subclavian catheter (Griffin & Hamilton, 2010). 
 
Virulence and Immune Evasion Factors 
S. aureus codes for an arsenal of virulence factors that are surface contained or 
released into the environment. Described below are some of these factors that help in 
adhesion, colonization, immune evasion, and infection dissemination. 
Protein A is a cell wall associated protein that has multiple virulence-associated 
functions. This surface exposed protein competitively binds to the Fc region of 
immunoglobulins like IgG, IgA, and IgE (Peterson, Verhoef, Sabath, & Quie, 1977; 
Lofdahl, Guss, Uhlen, Philipson, & Lindberg, 1983), thus preventing the staphylococcal 
cells from being marked for phagocytosis (Gemmell, Tree, Patel, O’Reilly, & Foster, 
1991). Protein A can behave as a superantigen if it interacts with the IgM molecules on 
the B-cells (DeDent, McAdow, & Schneewind, 2007; Dossett, Kronvall, Williams, & 
A B C 
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Quie 1969; Romagnani et al., 1981) leading to an increased immune response and more 
damage to the host. Menzies and Kourteva in 1998 also revealed the apoptotic effect of 
protein A on monocytes and macrophages (Menzies & Kourteva, 1998). Thus, protein A 
was proposed to be a very important virulence factor of S. aureus.  
MSCRAMMS (Microbial Surface Components Recognizing Adhesive Matrix 
Molecules) are surface exposed proteins that are covalently attached to the peptidoglycan 
layer. These proteins bind to host surfaces to aid in establishing an infection (Foster & 
McDevitt, 1994). 
Table 1 
Examples of MSCRAMMS 
 
MSCRAMMS 
 
Host protein 
 
Reference 
Fibronectin-binding protein 
(fnbpA and fnbpB) 
Fibronectin (Flock et al., 1987; Signas et al 1989; 
Jonsson, Signas, Muller, & Lindberg 
1991; Schwarz-Linek et al., 2003) 
Clumping factor (clfA and 
clfB) 
Fibrinogen (McDevitt, Francois, Vaudaux, & 
Foster, 1994; Bayer, Sullam, Ramos, 
Li, Cheung, & Yeaman, 1995) 
Collagen adhesion (cna) Collagen (Patti et al., 1992; Gillaspy, Lee, Sau, 
Cheung, & Smeltzer 1998) 
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Figure 4. MSCRAMMs (Microbial Surface Components Recognizing Adhesive Matrix 
Molecules) of S. aureus (Garcia-Lara, Masalha & Foster, 2005). 
 
S. aureus synthesizes a capsule (Lee, Xu, Albus, & Livolsi, 1994, Lee, Liang, 
Hook, & Brown., 2004b) around itself that protects the bacteria and prevents it from 
complement activation and opsonophagocytosis by preventing the neutrophil receptor 
from gaining access to the staphylococcal proteins (Thakker, Park, Carey, & Lee 1998; 
Nilsson, Lee, Bremell, Ryden, & Tarkowski,1997). Of the 11 capsule serotypes that have 
been identified, serotypes 5 and 8 have been found associated with human infections. 
Serotypes 5 and 8 are produced in small quantities and have proven to be difficult to 
study. Overexpression studies have shown that large quantities of capsule 8 showed 
longer persistence of the strains in the blood, liver, and spleen of mice in a sepsis model. 
The enhanced capsule production also showed increased resistance to 
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opsonophagocytosis (Luong, Sau, Gomez, Lee et al., 2004a, 2004b). S. aureus also 
produces several cytotoxins that have the ability to lyse leukocytes, monocytes and RBCs 
(Wardenburg, Bae, Otto, DeLeo, & Schneewind, 2007) (Table 2). 
Table 2 
Cytotoxins produced by S. aureus 
 
Cytotoxins 
 
Role in virulence 
 
References 
α – toxin Lyse red blood cells, platelets, 
endothelial and epithelial cells 
(Gray & Kehoe, 1984; Patel, 
Nowlan, Weavers, & Foster, 1987; 
Bhakdi et al., 1988, 1989; Bhakdi 
& Tranum-Jensen 1991; Bayer, 
Ramos, Menzies, Yeaman, Shen, 
& Cheung, 1997) 
β – toxin Lysis of erythrocytes (Projan, Kornblum, Kreiswirth, 
Moghazeh, Eisner, & Novick 
1989) 
γ – toxin and 
Leukocidin 
Lysis of leukocytes (Jayasinghe & Bayley, 2005) 
 
Several enzymatic virulence factors are secreted by S. aureus like proteases, 
lipases, and coagulases. Staphylococcus expresses various proteases. Unlike most of the 
extracellular secreted enzymes of S. aureus, coagulase is a surface associated enzyme 
(Kaida, Miyata, Yoshizawa, Igarashi, & Iwanaga, 1989) that coagulates serum by the 
reaction illustrated below (Lowy, 2000). 
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Coagulase + Thrombin    Staphylothrombin 
 
Fibrinogen   Fibrin (coagulation) 
Figure 5. Schematic representation of the process of coagulation by S. aureus. 
For a pathogen like S. aureus to establish an infection in the host, it is essential for 
the pathogen to withstand the immunological attack by the host. Thus, S. aureus has 
several immune evading mechanisms while encountering the host innate and adaptive 
immune system. In this study, the focus is on the evasion of phagocytosis, a common 
immune response that clears the host of pathogens and foreign bodies. Listed in Table 3 
are some of the evading mechanisms and factors employed by S. aureus at the various 
stages of phagocytosis.  
Table 3 
Immune evading factors produced by S. aureus  
 
Virulence Factors 
 
Mechanism of Evasion 
 
Reference 
Preventing Chemotaxis 
Chemotaxis Inhibitory 
Protein (CHIPs) 
Binds to neutrophil receptors for 
formyl peptides and C5a. Thus 
decreasing chemotaxis. 
(de Haas et al., 
2004; Haas et al., 
2004) 
MHC Class II analogous 
protein/extracellular 
adherence protein (Eap) 
Competes with lymphocyte-function-
associated antigen (LFA-1) for 
binding intercellular adhesion 
molecule-1 (ICAM-1). Prevents the 
binding of neutrophils with 
endothelial cells. Thus inhibiting 
chemotaxis and extravasation to the 
site of infection. 
(Chavakis, T. et 
al., 2002) 
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Table 3 (continued). 
 
Virulence Factors 
 
Mechanism of Evasion 
 
Reference 
Preventing Opsonization 
Protein A (Spa) Competitive binding to Fc region of 
immunoglobulin like Ig G, IgA and 
IgE. It also reduces the platelet 
aggregation 
(Uhlen, M., 
Guss, B., 
Nilsson, B., 
Gatenbeck, S., 
Philipson, L., 
Lindberg, 1984; 
Lofdahl, Guss, 
Uhlen, Philipson 
& Lindberg, 
1983; Gemmell, 
Tree, Patel, 
O’Reilly, & 
Foster, 1991) 
Clumping Factor (ClfA) Clump together by binding to each 
other and the fibrinogen to coat the 
cells and causing (1) Inhibition of 
opsonin deposition (2) Steric 
hindrance for opsonophagocytosis. 
(Palmqvist, Patti, 
Tarkowski & 
Josefsson, 2004) 
Capsular polysaccharide 
(Cap)  
Prevent opsonin deposition, or access 
to neutrophil receptors. 
(Thakker, Park, 
Carey, & Lee 
1998; Nilsson et 
al 1997) 
Staphylokinase (Sak) Plasminogen activator protein 
Dissolve fibrin clots 
Degrades IgG and C3 (after opsonins 
deposition has been initiated) 
Binds to defensin (an antimicrobial 
peptide) 
(Rooijakkers, 
van Wamel, 
Ruyken, van 
Kessel, & van 
Strijp, 2005a) 
Staphylococcus 
Complement Inhibitor 
(SCIN) 
Prevents the formation of C3b 
formation. Thus, interrupting the 
complement activation pathways. 
(Rooijakkers et 
al., 2005b) 
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Table 3 (continued). 
 
Virulence Factors 
 
Mechanism of Evasion 
 
Reference 
Escape a Phagosome 
α – Hemolysin, γ – 
Hemolysin, 
Panton-Valentine 
Leukocidin, 
Leukocidin E/D 
Assemble into a heptamer and form a 
pore in the membranes of the host 
cells. 
Escape from endosomes and 
phagocytes 
(Montoya & 
Gouaux, 2003) 
(Menestrina et 
al., 2003) 
Intracellular Survival 
Aureolysin (Aur) Cleaves the antimicrobial peptide 
human defensin peptide cathelicidin 
LL-37. 
(Sieprawska-
Lupa, M. et al., 
2004) 
 
Global Regulation 
The synthesis and action of virulence factors are coordinated and controlled by 
regulators. These regulators could be transcriptional regulators like Sigma factor B 
(Bischoff et al., 2004; Ziebandt et al., 2001), two-component systems like Staphylococcal 
accessory element (Sae) (Novick & Jiang, 2003), or RNA molecules like RNA III of the 
agr system (Janzon & Arvidson, 1990; Novick, Ross, Projan, Kornblum, Kreiswirth, & 
Moghazeh, 1993). Some the well-studied global regulators are the accessory gene 
regulator (Agr), staphylococcal accessory element (Sae), and the staphylococcal 
accessory regulator (SarA). 
The Agr System 
The Agr system (accessory gene regulator) was first studied in an agr mutant with 
a Tn551 transposon inserted into the agr locus (Mallonee, Glatz & Pattee, 1982; Recsei, 
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Kreiswirth, O'Reilly, Schlievert, Gruss, & Novick, 1986). Cloning and characterization of 
the agr gene showed the agr locus to code for a two-component system (Peng et al., 
1988). The agr locus consists of two transcripts: RNA II and RNA III that are under the 
promoters P2 and P3 respectively. The genes that code for RNA II are the agr B, agr D, 
agr C, and agr A, and the proteins coded by them regulate the RNA III production. The 
RNA III also codes for the hld, delta hemolysin. The production of RNA III is regulated 
by the agrBDCA genes. The agr system plays an important role in the synthesis of 
secreted proteins like toxic shock syndrome toxin (TSST-1), hemolysins, serine protease, 
and surface-associated proteins like protein A, coagulase, and fibronectin binding protein 
(Lindberg et al., 1990). 
 
Figure 6. The agr quorum system of S. aureus. (Camara, Williams, & Hardman, 2002) 
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A mutant of the hld gene did not produce an agr mutant, thus was not the effector 
of the agr system (Novick et al., 1993). Although when the role of RNA III in an agr 
system was studied by introducing a plasmid carrying the gene for RNA III into an agr 
strain it produced an agr+ phenotype. The agr complementation was also performed with 
a RNA II, which failed to produce an agr+ phenotype. Thus, RNA III was concluded to 
be the regulator of agr system. RNA III regulation of transcription and translation of 
target genes was independent of each other (Novick et al., 1993). The RNA III was 
observed to reach a maximum expression during the post-exponential phase 
(Vandenesch, Kornblum, & Novick, 1991). 
The Agr A and Agr C are the response regulators and the histidine kinase 
components of the two-component system. The Agr C is a 46 kDa transmembrane protein 
that consists of a sensor that recognizes AIP and a cytoplasmic transmitter that contains a 
histidine residue (Lina et al., 1998). This activation of Agr C is dose-dependent, and the 
maximal activation occurs at an optimum concentration of AIP. Activation of Agr C 
leads to autoinduction of agrBDCA and the synthesis of RNA III (Ji, Beavis, & Novick 
1997). The RNA III acts as the effector of the agr system, which increases transcription 
of secreted proteins and decreases transcription of surface proteins. The Agr D consists of 
an N-terminal region, followed by the AIP that gets cleaved off on processing and a C-
terminal region. Agr B has the endopeptidase activity by which it modifies the Agr D and 
secretes the AIP produced out of the cell (Zhang, Gray, Novick, & Ji 2002; Zhang & Ji, 
2004; Zhang, Lin & Ji, 2004). 
The agr system is classified into agr types I–IV, based on varying regions 
(hypervariable regions) (Dufour et al., 2002) in agrBDCA operon and they respectively 
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recognize the AIP types I – IV (Ji, Beavis, & Novick, 1997, 1997; Jarraud et al., 2000; 
McDowell et al., 2001; Otto, Echner, Voelter, & Gotz, 2001). 
The regulatory influence of agr on other genes is imparted by the binding of 
AgrA, binding of the RNA III molecule to the virulence genes under regulation or 
indirectly through the interaction of RNA III and Rot (repressor of toxins) (Geisinger, 
Adhikari, Jin, Ross, & Novick, 2006). Dunman et al., (2001) showed that agr increased 
expression of proteases, lipases, ureases, toxins (encoded by hla, hld, and hlb), and 
enterotoxins (SEB, SEC and SED) via the binding of RNA III component of the agr 
system (Dunman et al., 2001). Other factors regulated by agr are listed in Table 4.  
Table 4 
Regulation of virulence genes by agr 
 
Genes Positively Regulated by agr 
 
References 
α- hemolysin (hla) (Morfeldt, Taylor, von Gabain & 
Arvidson, 1995; Novick et al., 1993; 
Xiong et al., 2006) 
Aureolysin (aur) (Oscarsson, Tegmark-Wisell & Arvidson 
2006) 
Serine Protease (ssp) (Oscarsson, Tegmark-Wisell & Arvidson 
2006) 
Staphylokinase (sak) (Shaw, Golonka, Potempa & Foster, 
2004) 
Polysaccharide capsule (cap) (Luong, Sau, Gomez, Lee et al., 2004a, 
2004b; Dassy, Hogan, Foster & Fournier, 
1993) 
 14 
 
 
Table 4 (continued). 
 
Genes Negatively Regulated by agr 
 
References 
Protein A (spa) (Novick et al., 1993, Benito, Kolb, 
Romby, Lina, Etienne & Vandenesch, 
2000) 
Coagulase (coa) (Chevalier et al., 2010) 
Fibronectin binding protein (fnb) (Saravia-Otten, Muller &Arvidson 1997) 
 
The SarA System 
The SarA (staphylococcal accessory regulator) is a 124kDa dimeric DNA binding 
protein. The sarA locus that codes for SarA has three transcripts sar A, sar B, and sar C 
that are produced under three promoters P1, P2, and P3 respectively (Bayer et al., 1996; 
Manna, Bayer, & Cheung 1998). The P1 and P2 promoters require the sigma A, while the 
P3 promoter requires the sigma B factor (Deora, Tseng, & Misra, 1997; Manna, Bayer, & 
Cheung, 1998). This DNA binding protein is expressed in the mid- and late-exponential 
phase of growth (Rechtin et al., 1999; Bayer et al., 1996). 
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Figure 7. The sarA system and the influence of SarA on other genes. (Cheung & Zhang, 
2001) 
 
In in vitro studies, Sar A has been observed to bind to several promoter regions of 
genes like hla, fnA, and fnB and upregulate them (Cheung, Koomey, Butler, Projan, & 
Fischetti, 1992; Cheung & Ying, 1994, Wolz et al., 2000). The sar A however, down-
regulates expression of genes like the serine protease (SspA) and cysteine protease 
(ScpA) (Lindsay & Foster, 1999). The ica gene locus encodes the PIA (Polysaccharide 
Intercellular Adhesin) biosynthesis. This gene locus consists of the ica A, ica D, ica B, 
and the ica C genes along with the negative regulator ica R. The ica A promoter and the 
ica R are regulated by the sar A (Tormo et al., 2005b). 
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Pathogenesis 
S. aureus are opportunistic pathogens that cause a variety of infections once they 
gain access to the host through hair follicles, open skin of cuts, incisions, injections, 
wounds, surgical wounds, or in-dwelling catheters. The infections caused by S. aureus 
range from localized superficial infections like abscesses, impetigo, and carbuncles to 
invasive infections like septic arthritis, osteomyelitis, and endocarditis (Figure 7) (Lowy, 
1998). 
S. aureus is one of the major causative agents of the gram-positive mediated 
sepsis. It is not the infecting pathogen by itself but the excessive host immunological 
response to this invader that causes the increased damage to the host (Angus et al., 2001). 
In an epidemiology study conducted on the incidence of sepsis from 1979 to 2000, S. 
aureus was reported to be the causative agent responsible for 52% of the cases (Martin, 
Mannino, Eaton, & Moss, 2003). Angus et al. (2001) reported a sepsis-associated 
mortality percentage of about 30, which increased to 40% with senior citizens in spite of 
being under hospital care and antibiotic treatment. Of this percentage, 40 % was incurred 
by gram positive infections (Angus et al., 2001; Alberti et al., 2002).  
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Figure 8. Pathogenesis model of S. aureus (Clark & Company, 1998) 
S. aureus is subject to attack by both the innate and acquired immune system. On 
entering the host, S. aureus can establish an infection either at the site of entry, or if it 
evades the immune system it could even cause severe systemic infections (Table 5). 
Infection leads to inflammation that signals phagocytes to the site. These phagocytes 
secrete antimicrobial substances to kill the bacteria as well as secrete signals to attract 
more phagocytes (chemotaxis) to the site of infection to clear the pathogens. The 
outcome of the immunological attack decides the fate of the staphylococcal invasion. 
This determines the extent of infection dissemination and severity. The other factors that 
ease the establishment of a staphylococcal infection are age and compromised immune 
systems. 
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Table 5 
Some of the sites of infections caused by S. aureus 
 
Sites for Infections 
 
S. aureus infected 
Skin and Soft Tissue Infections 
(SSTIs) 
76% of total purulent SSTIs  in 11 emergency 
departments
a
 
In-dwelling Device Infections 7.3% of all S. aureus infections
b
 
Post-surgical Infections 10.1% of all S. aureus infections
b
 
Urinary Tract Infections 3.6% of all S. aureus infections
b
 
Note.  a – In 2004 (Moran et al., 2006); b – In 1999 – 2000 (Kuehnert, et al., 2005) 
Methicillin Resistant Staphylococcus aureus (MRSA) 
Methicillin Resistant Staphylococcus aureus are S. aureus that have the ability to 
build resistance to most antibiotics like the penicillins–flucloxacillin, oxacillin, and 
methicillin. Methicillin was the antibiotic used to treat penicillin resistant S. aureus 
infections in the past until the 1960s when the first case of MRSA was found in the 
United Kingdom (Jevons, 1961). In a study conducted with data from 1,268 ICU sections 
of 337 hospitals from 1992 to 2003 alone, the MRSA positive infections increased from 
35.9% to 64.4% among the S. aureus isolates (Klevens et al., 2006). Based on the 
statistical information by the Centers for Disease Control and Prevention of the S.aureus 
and MRSA Surveillance Summary 2007 in the US, there have been 292,000 cases of 
hospitalizations that are positive for S. aureus infections annually (Kuehnert et al., 2005). 
MRSA infections cause a large degree of stress on the healthcare sector owing to 
its high mortality rate, lack of treatment success, and cost. Several types of genotypic 
typing have been conducted ever since the realization of the endemic spread of MRSA 
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infections. Some of the methods used to classify the various S. aureus isolates are 
classifications by antibiotic susceptibility, any phenotypic characteristic, sequence of spa 
gene that encodes for the Protein A, Pulsed-field gel electrophoresis (PFGE, DNA-based 
finger printing method), and Multilocus Enzyme Electrophoresis (MLEE). These 
methods were soon taken over by Multilocus sequence typing (MLST). Genotypic typing 
comparisons of the first MRSA isolate in the UK in 1961 and the MSSA that were 
prevalent in Denmark in the 1950s revealed no difference (Crisostomo, Westh, Tomasz, 
Chung, Oliveira, & Lencastre, 2001) except for the mobile genetic element 
Staphylococcal Cassette Chromosome – SCCmec (Katayama, Ito, & Hiramatsu, 2000). 
The SCCmec element carries the mecA gene that codes for the PBP 2’ or PBP2a 
(Penicillin binding protein 2’), which confers antibiotic resistance to β-lactam antibiotics 
(Hartman & Tomasz, 1984; Reynolds & Brown, 1985; Utsui & Yokota, 1985). 
Crisostomo and group thus suggested that MRSA strains might have descended from 
MSSA isolates (Crisostomo et al., 2001). Unlike HA-MRSA SCCmec types of I–III, CA-
MRSA strains carry the SCCmec type IV (Okuma et al., 2002, Vandenesch et al., 2003). 
While most infections were found associated with individuals who have had a 
prior exposure to the healthcare setting or have been in close contact with other 
individuals (Saravolatz, Markowitz, Arking, Pohlod, & Fisher, 1982a; Saravolatz, 
Pohlod, & Arking, 1982b; Thompson, Cabezudo, & Wenzel, 1982; Boyce, 1998; 
Graffunder & Venezia, 2002; Lodise, McKinnon, & Rybak, 2003), Community 
Acquired-MRSA infections were found in individuals who have had no prior encounters 
to the clinical setting or any pre-disposing factors (Crum et al., 2006; Naimi et al., 2003). 
In an epidemiological study conducted from July 2004 to December 2005 in the US, it 
was reported that of the invasive infections recorded, 58.4% of them were community 
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onset HA-associated, 26.6% hospital onset HA-acquired, and 13.7% were CA-MRSA 
infections (Klevens, Morrison, & Nadle, 2007). 
Hospital-Acquired Staphylococcus aureus 
Based on the epidemiologic classification of invasive MRSA infections, health 
care associated MRSA infections were classified into two types: (a) community onset and 
(b) hospital onset. Community onset heath care-associated MRSA infections were 
defined as “cases with at least 1 of the following health care risk factors: (1) presence of 
an invasive device at time of admission; (2) history of MRSA infection or colonization; 
(3) history of surgery, hospitalization, dialysis, or residence in a long-term care facility in 
previous 12 mo preceding culture date” (Klevens et al., 2007, p. 1765). Hospital onset 
health care-associated MRSA infections were defined as “Cases with positive culture 
result from a normally sterile site obtained >48 h after hospital admission. These cases 
might also have ≥1 of the community-onset risk factors” (Klevens et al., 2007, p. 1765). 
In a study conducted between the years 1992–2003, HA-MRSA causing infections 
reached a high percentage of 64.4% of the infections of intensive care units in the US 
(Klevens et al., 2006). Based on the antibiotic resistance gene, the type of recombinase 
gene and the number of them, the SCCmec are classified into five classes (Ito et al., 
2002; Okuma et al., 2002). SCCmec found in HA-MRSA isolates are SCCmec I-III (Ito 
et al., 2001; Enright et al., 2002). The PFGE types USA100, USA200, and USA500 are 
common among HA-MRSA infections. 
Community-Acquired Staphylococcus aureus 
Based on the epidemiologic classification of invasive MRSA infections, cases of 
community-acquired infections were defined as “cases with no documented community-
onset health care risk factor” (Klevens et al., 2007, p. 1765). Community-acquired 
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MRSA strains were first reported in 1981 in Detroit among intravenous drug abusers 
(Saravolatz et al., 1982a). Mortality-associated CA-MRSA infections were soon reported 
a few years later in 1997 in Minnesota and North Dakota (CDC, 1999). In 2006, Moran, 
et al. published evidence of CA-MRSA causing SSTIs in emergency departments. CA-
MRSA reported had a diverse prevalence from children under child care (Adcock, Pastor, 
Medley, Patterson, & Murphy, 1998), to sports members (CDC report 2003; Begier et al., 
2004), to correctional facilities (CDC, 2003). Infections among the community without 
prior exposure to a health setting was not the only alarming feature of CA-MRSA 
infections, these SSTI causing strains also caused severe, invasive infections that have 
been morbidity-associated ones (Naimi et al., 2003; Zetola, Francis, Nuermberger, & 
Bishai, 2005; Kaplan et al., 2005; Fridkin et al., 2005). 
Unlike most strains of S. aureus, CA-MRSA strains reside relatively longer on the 
human skin than in the nasal passages (Mertz et al., 2007; Shurland et al., 2007). This site 
of colonization makes pathogens like CA-MRSA very accessible for transmission, which 
could be one of the contributing factors to the contagiosity of CA-MRSA infections 
(Nguyen, Bancroft, Mascola, Guevara, & Yasuda, 2007). 
Pulse-field gel electrophoresis (a RFLP based technique) is one the most common 
and established modes of local-level genotypic typing followed in the United States. The 
Center for Disease Control and Prevention identified two notorious clones of CA-MRSA 
strains prevalent in the US by PFGE: USA300 and USA400 (McDougal et al., 2003). The 
USA300 PFGE type (Tenover et al., 2006) was among the most pathogenically dominant 
CA-MRSA strains (Li et al., 2009). The other PFGE types associated with the CA-MRSA 
strains were USA400, USA1000, and USA1100 (McDougal, Wenming, Patel & Tenover, 
2004). 
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Strains of USA300 are MRSA (Diep et al., 2006). Presence of the genes of 
Panton-Valentine leukocidin (PVL), enterotoxin Q, enterotoxin K, and arginine catabolic 
mobile element (ACME) are unique to the USA300 strains (Diep et al., 2006). The 
ACME is a 30.9 kb acquired genetic element that carries the arc gene cluster. The arc 
gene cluster codes for the enzymes required for conversion of L-arginine to metabolically 
important products like ATP, carbon-dioxide, and ammonia. Nitric oxide (NO) is an 
important player in the immune system of the host; thus, unavailability of L-arginine, the 
precursor of NO, is believed to aid in surviving the hostile immunological attacks on 
bacteria (Diep et al., 2006; Degnan et al., 1998, 2000). 
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CHAPTER II 
BACKGROUND 
The msa Gene 
While screening using a Tn551 library, a novel gene was identified to be involved 
in the regulation of sar A – the msa (Modulator of sar A) gene. Mutation of this msa gene 
has been seen to affect the expression of sar A and several virulence-related genes in the 
S aureus strains COL, RN6390, and UAMS-1 (Sambanthamoorthy, Smeltzer, & Elasri, 
2006) (Table 2.1). The mutant of msa was also observed to be unable to form mature 
biofilms, a hallmark feature of S. aureus. (Sambanthamoorthy, Smeltzer, & Elasri, 2006; 
Sambanthamoorthy, Schwartz, Nagarajan, & Elasri, 2008). 
Table 6 
Genes previously known to be regulated by msa 
 
Extracellular factors 
 
Surface factors 
α-hemolysin(hla) Clumping factor A (clfA) 
Aureolysin (aur) Protein A (spa) 
V8 proteases(ssp) Collagen adhesin (cna) 
Lipase (lip) Fibronectin (fnb) 
 
The sequence of the msa sequence was analyzed by computational analysis and 
predicted to be a 15.67kDa transmembrane protein with three transmembrane regions. 
The positions of the potential phosphorylation sites further suggested that the Msa protein 
could be a membrane protein functioning as a signal transducer (Nagarajan & Elasri, 
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2007). Additional research on the msa mutant by microarray analysis showed that the 
msa gene regulated several genes (unpublished data) which, strongly suggested that the 
msa gene could be a global regulator like sarA or the agr system. At the amino acid level, 
the Msa sequence shows homology and conservation across several strains like RF122, 
MRSA252, MSSA476, MW2, COL, Mu50, N315, and NCTC 8325 (Nagarajan & Elasri, 
2007). 
Strain S. aureus UAMS-1 
The S. aureus strain UAMS-1 was isolated from an osteomyelitis patient from the 
McClellan Veterans Hospital in Little Rock, Arkansas (Gillaspy et al., 1995). Animal 
model studies have shown UAMS-1 strains to be very proficient in osteomyelitis and 
septic arthritis (Blevins et al., 2003; Smeltzer et al., 1997). UAMS-1 strains of S. aureus 
are methicillin susceptible, host acquired strains (Gillaspy et al., 1995). The α-hemolysin 
gene, hla of UAMS-1 carries a nonsense mutation thus UAMS-1 is unable to synthesize 
the toxin (Cassat et al., 2006) but this has not influenced the pathogenicity of UAMS-1 
strains. UAMS-1 strain was used for this study as a representative of a hospital acquired 
strain. 
Strain S. aureus USA300 – 0114 LAC 
Most clinically relevant strains belonging to the PFGE type USA300 are of the 
subtype USA300-0114 (McDougal et al., 2003; Tenover et al., 2006). The USA300 strain 
FPR3757 was isolated from an abscess on the wrist of a HIV-positive male at the San 
Francisco General Hospital (Pan et al., 2005). This strain was used in this study as a 
representative of a community acquired clinical isolate. 
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Comparison of S. aureus Community-Acquired Isolate USA300 LAC vs Hospital-
Acquired Isolate UAMS-1 
The regulatory role of the msa gene was studied in the genetic backgrounds of 
LAC and UAMS-1. Here, a comparison was made between these two strains to 
understand the behavior of the msa gene in these two genetic backgrounds. Nagarajan et 
al. showed conservation of the msa gene across very strains of S. aureus, yet the 
regulatory behavior of the msa gene has showed variations across these strains 
(Nagarajan & Elasri, 2007; Sambanthamoorthy, Smeltzer, & Elasri, 2006). Thus, to better 
understand the regulation by the msa gene in the strains of S. aureus, previous findings 
on the genetic content of LAC and UAMS-1 were gathered and compared in Table 7. 
Table 7 
Comparison of S. aureus community acquired isolate USA300 LAC vs hospital acquired 
isolate UAMS-1 
  
USA300 LAC 
 
References 
 
UAMS-1 
 
References 
First 
isolated  
Abscess isolate, 
USA, 2000 
(Diep et al., 
2006) 
Bone isolate from a 
Osteomyelitis 
patient, Little Rock, 
AR, 1995 
(Gillaspy 
et al., 
1995) 
PFGE USA300 (subtype 
0114) 
(Kennedy et 
al., 2005, 
Francis et al., 
2005, Miller et 
al., 2005)  
USA200  
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Table 7 (continued). 
  
USA300 LAC 
 
References 
 
UAMS-1 
 
References 
MLST ST8 (Enright et al., 
2000, Miller et 
al., 2005) 
ST30 (Cassat et 
al., 2005) 
Spa type YHGFMBQBLO, 
spa1 
(Shopsin et 
al., 1999, 
Miller et al., 
2005)  
WGKAKAQ, 
spa33 
(Cassat et 
al., 2005) 
SCCmec SCCmec Iva (Ma XX et al., 
2002, 
Robinson et 
al., 2005, 
Miller et al., 
2005) 
None (Gillaspy 
et al., 
1995) 
Methicillin 
susceptibility 
MRSA (Diep et al., 
2006) 
MSSA (Gillaspy 
et al., 
1995) 
Agr 
subgroub 
Type I (McDougal et 
al., 2003) 
III (Cassat et 
al., 2005) 
ACME Present (Type I) (Diep et al., 
2006) 
Absent (Zhu et al., 
2007; Fey 
& Olson, 
2010) 
 27 
 
 
CHAPTER III 
DELETION OF THE MSA GENE 
Introduction 
Previous to this study, the role of msa was studied using an insertional mutant 
which, provided good evidence that msa is required in regulating virulence and biofilm 
formation (Sambanthamoorthy, Smeltzer, & Elasri, 2006; Sambanthamoorthy, Schwartz, 
Nagarajan, & Elasri, 2008). But, insertional mutants have several disadvantages. There is 
always a possibility of a truncated product being formed due to the upstream part of the 
open reading frame in question being intact. Additionally, if the gene is part of an operon, 
the insertional mutation can hamper the transcription of the neighboring genes. Taking all 
these potential polar effects of insertional mutants into consideration, the msa gene was 
mutated by deletion. 
A temperature sensitive shuttle vector pKOR1 was used to delete the msa gene 
from S. aureus strains COL, LAC, RN6390, and UAMS-1. At the non-permissive 
temperature of 43˚C, pKOR1 integrates into the chromosome and at 30˚C, which is the 
permissive temperature the plasmid eviction is favored. This eviction facilitates the loss 
of the msa gene. One of the special features of pKOR1 is that it offers an inducible 
counter selection with anhyrotetracycline (ATc) that selects for chromosomal excision 
and loss of plasmid without the use of an antibiotic. 
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Figure 9. Schematic representation of the temperature sensitive pKOR1 vector employed 
to create deletion mutants of S. aureus. Labels indicated: attP sites = attachment sites P1 
and P2, cat sites = chloramphenicol resistance sites for gram positive [cat (+)] and gram 
negative [cat (-)] hosts, bla = ampicillin resistance gene, tetR = tetracycline resistance 
gene, Pxyl/tetO = promoter producing the antisense product for the protein required for 
protein translocation. 
 
 
Figure 10. Schematic representation of the insert preparation containing the Upstream 
and Downstream regions of msa gene to be inserted into the pKOR1 vector. 
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Materials and Methods 
Bacteria and Growth Conditions 
The bacterial strains of Staphylococcus aureus were grown in Tryptic Soy Broth 
(TSB) and Tryptic Soy Agar (TSA) at the required temperatures and in the presence of 
appropriate antibiotics. The plasmid pKOR1 was used to delete the msa gene from the 
chromosomal DNA. The pKOR1 transformations were carried out in Escherichia coli 
and S. aureus RN4220. The Phage φ11 was also employed to transfer pKOR1 from S. 
aureus RN4220 to the strains of S. aureus COL, USA300 LAC (Los Angeles county 
clone), RN6390, UAMS-1. 
Allelic replacement with pKOR1 
The gene msa in S. aureus strains were mutated by deletion using the mutagenesis 
protocol described by Bae and Schneewind (Bae & Schneewind, 2006). Briefly, the 
flanking regions of the msa gene were amplified from Staphylococcus aureus with 
primers listed in Table 8 by PCR. The DNA fragments isolated were digested with the 
restriction enzyme BamHI and ligated using T4 DNA ligase. This ligated fragment was 
amplified using the F-UR and R-DR primers and was inserted into pKOR1 using the 
Gateway BP Clonase Enzyme Mix (Invitrogen’s Corp.). The plasmid thus formed 
pKOR1-∆msa was introduced into TOP 10 cells (Invitrogen’s Corp.) by chemical 
transformation and then into S. aureus RN4220 by electroporation. The plasmids isolated 
were verified by sequencing and transferred into the respective strains of S. aureus by φ 
11-mediated phage transduction. The plasmids isolated were again verified by PCR and 
sequencing. 
S. aureus strain containing the pKOR1-∆msa was cultured overnight in TSB at 
30˚C in the presence of chloramphenicol (7.5µg/ml). A plate of TSA containing 
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chloramphenicol (7.5µg/ml) was streaked with the overnight culture and incubated at 
43˚C overnight. The colonies thus formed were picked and inoculated in plain TSB and 
allowed to grow overnight at 30˚C. The following day a dilution of 10-4 were prepared 
from the overnight cultures and plated on TSA containing 100ng/ml of 
anhydrotetracycline. This temperature shift from 30˚C to 43˚C was repeated once more. 
The colonies thus formed were picked and streaked on both plain TSA and TSA 
with chloramphenicol. The colonies that grew only on TSA plates were selected and 
analyzed for mutation of the msa gene. The co-integration protocol followed is as 
described by Bae and Schneewind (2006).  
Table 8 
Primers used for isolating the flanking regions of the msa gene 
 
Regions 
 
Primer 
 
Sequence 
Upstream 
Region (UR) 
F-UR GGGGACAAGTTTGTACAAAAAAGCAGGCTCTGCGTCA
TCCCCTTG 
R-UR ATTAGGATCCAACAACGTTTGCAGCTTGTG 
Downstream 
Region (DR) 
F-DR TGTTGGATCCTGGTATGTATATGATGCT 
R-DR GGGGACCACTTTGTACAAGAAAGCTGGGTTACCAT
CGCGCATTTA 
Note. Region in italics are the att sites and the region underlined the Restriction site of BamHI. 
Verification of the Deletion Mutant 
The mutants of msa were verified by the following methods: 
(1) PCR: In order to verify the mutation of the msa gene from the chromosome of S. 
aureus, chromosomal DNA was isolated from the potential mutants and tested by 
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PCR using the (A) F-UR and the R-DR primers (Figure 11) and (B) the msa open 
reading frame primers. 
(2) Sequencing: The regions amplified by PCR using the F-UR and R-DR primers 
were cloned into pCR2.1 (TOPO vector, Invitrogen Inc.). These vectors were sent 
for sequencing with F-UR, R-DR primers, and the F-UR-SEQ primer. 
 
 
Figure 11. Schematic representation of the expected msa mutation. 
Complementation 
The open reading frame of msa along with the upstream region containing the 
msa promoter was inserted into pLi50 and introduced into the msa mutant strains to serve 
as the complement. Since, pLi50 was a high copy number vector, complementation was 
also attempted with a low copy vector pCN34 (requested from NARSA). 
Phenotypic Characterization 
Biofilm assay.A 20% solution of human plasma was prepared and 200µl of this 
solution was added to the wells of a microtiter plate and incubated at 4˚C to coat the 
wells. The next day the plasma was carefully aspirated and the wells were washed thrice 
with 1X PBS. Overnight cultures of the testing strains were normalized (with TSB 
containing 3% NaCl and 0.5% glucose) and added to the respective wells. The plates 
were incubated at 37˚C. The contents of the wells were aspirated and washed with 1X 
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PBS. Following washing, 100% of ethanol was used for fixing (10 min) and crystal violet 
for staining (2 min). The stain was washed with PBS and the plate was allowed to dry 
overnight inverted. 
Protease assay. The strains were grown overnight in TSB at 37˚C. The following 
day 300µl of the culture supernatant was filtered and incubated overnight at 37˚C with 
800 µl of Azocasein (3mg/ml) in Tris buffered saline (pH 7.5). The undegraded azocasein 
was precipitated by 50% trichloroacetic acid and the protease activity was assayed by 
measuring the amount of acid-soluble azocasein spectrophotometrically at 340 nm 
(Smeltzer et al., 1993). 
Hemolytic assay.The strains were grown in TSB at 37˚C with shaking at 120 
rpm. The following day, the cultures were normalized to the lowest OD at 560nm. 
Supernatants were collected and filtered. Ten microliters of supernatant was mixed with 
1ml of 2% rabbit blood in 10mM Tris HCl (pH 7.5) – 0.9% NaCl. This was incubated at 
37˚C for 15 minutes. The lysed cells were separated from the supernatant and the 
supernatant was used to measure optical density (OD) at 405nm. TSB and 1% SDS were 
used as negative and positive controls respectively (Blevins et al., 2002). 
Results 
Mutants of S. aureus strains LAC, UAMS-1, RN6390 and COL were verified as 
described. Figure 12 shows the absence of the msa gene in the mutant strains of S. 
aureus. Individual strains of LAC, UAMS-1 and COL were also verified by the ACME 
region (Figure 13), cna gene (Figure 14), and tetracycline resistance (Figure 3.7) 
respectively.
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Figure 12. PCR with msa primers to verify the deletion of the msa gene in the S. aureus 
strains of LAC, UAMS-1, RN6390, and COL. 
 
 
 
Figure 13. PCR with primers specific for the ACME region (unique for USA300 LAC 
strains) to confirm the genetic background of S. aureus LAC strains. 
1 = LAC 
2 = LAC Δmsa 
3 = UAMS-1 
4 = UAMS-1Δmsa 
5 = RN6390 
6= RN6390Δ msa 
7 = COL 
8 = COL Δmsa 
1 = LAC 
2 = LAC Δmsa 
3 = UAMS-1 
4 = UAMS-1Δmsa 
5 = RN6390 
6= RN6390Δ msa 
7 = COL 
8 = COL Δmsa 
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Figure 14. Verification by PCR of S. aureus UAMS-1 (unique for UAMS-1 strain) by the 
presence of the cna gene of S. aureus UAMS-1 strains. 
 
 
Figure 15. Tetracycline test with S. aureus COL strains confirming the strains of S. 
aureus COL strains. 
1 = LAC 
2 = LAC Δmsa 
3 = UAMS-1 
4 = UAMS-1Δmsa 
5 = RN6390 
6= RN6390Δ msa 
7 = COL 
8 = COL Δmsa 
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Growth Curve 
Growth curves of the strains of S. aureus LAC and UAMS-1 strains showed that 
deletion of the msa gene did not affect the growth of the strains (Figures 16 and 17).  
 
Figure 16. Growth Curve of S. aureus UAMS-1 strains showing that the deletion of the 
msa gene of S. aureus UAMS-1 does not influence the viability of S. aureus UAMS-1. 
 
 
Figure 17. Growth Curve of S. aureus LAC strains strains showing that the deletion of 
the msa gene of S. aureus LAC does not influence the viability of S. aureus LAC. 
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Phenotypic Characterization 
Biofilm Assay. Wild type strains of S. aureus COL have the ability to produce 
biofilms and Sambanthamoorthy et al. (2006, 2008) showed that insertional mutation of 
msa reduced the biofilm formation. These previous findings matched the observations of 
the biofilm assay with the deletion mutants of S. aureus COL (Figure 18). 
 
Figure 18. Biofilm Assay of S. aureus COL strains showing the weak biofilm fomation in 
the msa mutants. Control wells contained uninoculated media to represent negative 
controls. 
 
Protease assay. Protease activity of S. aureus COL was also assessed and showed 
that deletion of the msa gene increased the protease activity of the strains (Figure 19). 
This phenotype was also observed in the insertional mutants of S. aureus COL 
(Sambanthamoorthy, Smeltzer, & Elasri, 2006). 
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Figure 19. Protease Activity of S. aureus COL strains showing increased protease 
activity in the msa mutants compared to the wild type strains. Un-inoculated media was 
used as a negative control. 
 
Hemolytic assay. Deletion of the msa gene reduced hemolytic activity of the S. 
aureus COL strain. The reduced hemolytic activity of the deletion mutants of S. aureus 
COL (Figure 20) were similar to that observed by Sambanthamoorthy et al. (2006). 
 
Figure 20. Hemolytic Assay of S. aureus strains of COL showing reduced hemolytic 
activity on deleting the msa gene. Un-inoculated media and 2% SDS solution were used 
as a negative and positive control, respectively. 
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Discussion 
The msa gene was successfully deleted from the S. aureus strains of COL, 
USA300 LAC, UAMS-1, and RN6390. Phenotypic characterizations observed with the 
msa mutant of COL were similar to that of the insertional mutants (Sambanthamoorthy, 
Smeltzer, & Elasri, 2006; Sambanthamoorthy, Schwartz, Nagarajan, & Elasri, 2008). 
Further studies on virulence and immune evasion were conducted with mutants in 
the USA300 LAC and UAMS-1 strains. Hence, to ensure the mutation of msa did not 
affect the viability of the strains, growth of the wild type was monitored along with the 
mutant. As seen in Figures 16 and 17, mutation of msa did not affect the growth and 
viability of the strains. Thus, the deletion mutants of the msa gene were employed to 
explore the features of global regulation in S. aureus. 
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CHAPTER IV 
MSA REGULATES IMMUNE EVASION, HOST PERSISTENCE AND 
DISSEMINATION IN THE CLINICAL ISOLATES OF STAPHYLOCOCCUS AUREUS 
Abstract 
Staphylococcus aureus is an opportunistic pathogen residing usually on the skin 
and nasal passages of humans. On gaining entry into the host, S. aureus has the ability to 
colonize and cause localized infections or spread and infect organs on the path of 
dissemination. The msa gene of S. aureus has been previously observed to regulate 
several virulence genes. Here in this study, we examined the influence of the msa gene on 
the regulation of immune evasion, host persistence, and dissemination employing the 
hospital-acquired strain S. aureus UAMS-1 and community-acquired strain S. aureus 
USA300 LAC. The murine sepsis model used to study host persistence and 
dissemination, showed that deleting the msa gene of UAMS-1 decreased the microbial 
surviving load in the lung, whereas the mutation in LAC showed no change in 
dissemination and colonization. The msa mutant in UAMS-1 also showed a decrease in 
survival in blood and in phagocytic-intracellular survival while in LAC the mutation 
showed no deterrence. On investigating the immune evasion factors regulated by the msa 
gene, we found significant fold changes in the expression of the scn, clfA, spa, aur and 
sak genes that play specific roles of evasion at the various stages of phagocytic uptake, 
namely chemotaxis, opsonization, and phagocytosis. Comparing the regulation of the msa 
gene on the individual factors in the two strains we observed the differential regulatory 
behaviour by the msa gene. While in LAC, the msa mutation decreased only the clfA 
levels in UAMS-1, the msa mutation decreased scn, clfA, spa, aur, and sak genes. In 
addition, the msa gene increased aur levels in LAC, but in UAMS-1 it decreased the aur 
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levels. Thus, we have not only observed the regulatory effect of msa on staphylococcal 
immune evasion but also the strain-dependent variation of this regulation. In addition, 
this study shows more evidence of the undeterred virulence of the community acquired 
USA300 LAC strains. 
Introduction 
Staphylococcus aureus, we know causes a broad spectrum of infections that range 
from superficial skin infections like folliculitis, and carbuncles, to more severe 
endocarditis, and osteomyelitis. Additionally, S. aureus causes sepsis–a clinical 
syndrome caused by entry of a pathogen into the blood stream whose severe clinical 
manifestations are caused more by the host response to the pathogen than the pathogen 
itself. Sepsis is characterized by the extensive inflammation along the path of the blood 
stream which includes the liver, kidney, lungs, and the cardiovascular system on the 
whole. Components of the S. aureus cells like peptidoglycan or the sheer presence of the 
organism can trigger the release of cytokines, chemokines, and several inflammatory 
mediators from the epithelial, endothelial, and other stimulated cells of the immune 
system. Thus, in order to study the role of the msa gene in host persistence and metastasis 
of infection we employed a murine sepsis model. 
One of the most common causes of septicemia caused by post-surgical infections, 
tissue trauma, and indwelling device-related infections is due to MRSA. Kreisel and 
colleagues, while studying cases of bacteremia caused by USA300 and non-USA300 
MRSA, pointed out that 25% of the cases were caused by USA300 MRSA, the skin and 
soft tissue infection causing strains (Kreisel et al., 2011). 
CA-MRSA strains have been observed to be more resilient than the Hospital 
acquired MRSA (HA-MRSA) strains (Voyich et al., 2005). Voyich et al. pointed out that 
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the increased virulence seen with USA300 strains was due to its ability to resist PMN 
killing and cause host cell lysis possibly by the secreted and surface associated virulence 
factors (Voyich et al., 2005; Diep et al., 2006; Foster, 2005). The hallmark of sepsis is the 
severe host-associated damage caused by the immune system. This severity and longevity 
is largely contributed by the persistence of the S. aureus CA-MRSA strains in the host. 
This recalcitrance of CA-MRSA strains is still not completely understood. Studying the 
behavior of msa in the sepsis model, phagocytic evasion, and infection dissemination we 
hoped would help understand staphylococcal sepsis and virulence and shed light on the 
recalcitrant pathogenicity of USA300 strains of S. aureus. 
The msa gene has been seen to regulate several virulence factors and, thus, 
proposed to play a vital role in virulence (Sambanthamoorthy, Smeltzer, & Elasri, 2006). 
These virulence factors have also been observed to play a role in immune evasion. 
Persistence of the pathogen in sepsis is largely contributed by the fact that the pathogen 
can co-exist with the very immune factors that are trying to destroy it; in other words, 
sepsis is possible by immune evasion. Thus, we investigated the role of msa in immune 
evasion especially in the phagocytic evasion of the neutrophils, an important member of 
the innate immune system. Here, we observed the role of msa in immunological 
clearance of a CA–isolate (USA300 LAC strain) in comparison with a HA–clinical 
isolate (UAMS-1). Employing these two strains, we studied if and how msa is one of the 
regulators required for the evasion of the innate immune system and pathogen persistence 
in a host. 
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Methods and Materials 
Strains and Growth Conditions 
The isolates S. aureus UAMS-1 and that of USA300 lineage LAC were used for 
this study. The msa gene was mutated by allelic replacement using pKOR-1 as described 
in Chapter III. Complementation was achieved using pCN34. All cultures were grown in 
TSB, Todd Hewitt Broth (THB), pooled human blood (Bioreclamation LLC), or horse 
blood (Thermo Fisher Scientific Inc.) according to the experimental need at 37°C. The 
complements of the msa mutants were selected by kanamycin (50 µg/ml). 
Sepsis Model 
Ten six-week old CD1 Swiss, outbred and immunocompetent mice (Charles River 
Laboratories) where inoculated with 10
8
 of wild type and mutant bacteria belonging to 
the strains of USA300 LAC and UAMS-1, while control mice where inoculated with 
PBS. These bacteria were administered in the tail intravenously in a 100 µl bolus (in 
DPBS). Mice were monitored every 3
rd
 hour for 24 hours followed by every 8
th
 hour for 
72 hours. 
Blood Survival Assay 
To assess the ability of S. aureus to survive in blood, the strains of S. aureus 
USA300 LAC and UAMS-1 were inoculated in gender pooled whole human blood and 
incubated at 37°C for 3 hours. Samples were collected at the 0 and 3
rd
 hour, serially 
diluted and plated. The colony forming units were counted after 18 hours of incubation at 
37°C. 
Growth Curve and Viability Assays 
The bacterial strains were grown in TSB with a starting OD 600 = 0.05. Optical 
density was measured every 30 min and plotted against time. For viability counts, cells 
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were collected at the exponential phase of growth, serially diluted and plated on TSA. 
The colony forming units were counted after 18 hours of incubation at 37°C.  
Neutrophil Isolation 
Neutrophils were isolated from blood obtained from healthy human volunteers. 
An informed consent approved by the Institutional Review Board at The University of 
Southern Mississippi was obtained from the volunteers. Briefly, Ficoll-Plaque PLUS (GE 
Healthcare Biosciences) was mixed with freshly obtained whole blood at a ratio of 1:2. 
This mixture was centrifuged at 400 x g for 30 – 40 min at 20°C. The layers containing 
plasma, lymphocyte, and Ficoll were removed. The pellet was re-suspended to its original 
volume. Equal volume of dextran/saline solution was added and mixed gently. This 
suspension was allowed to stand at 25-45 degree angle for an hour at room temperature 
followed by a 90 degree angle for 10 min. The suspension separated into two distinct 
layers: the upper clear PMN layer and the lower layer. The PMN layer was carefully 
transferred to a clean tube and spun down for 1500 rpm for 10 min. The resulting pellet 
was re-suspended in 10 ml of 0.2% NaCl and the RBCs were lysed by gently pipetting up 
and down for 1-2 min. Following this, 1.6% NaCl was added and spun down at 1500 rpm 
for 10 min. The resulting PMNs were re-suspended in the desired volume of RPMI plus 
10% Fetal Bovine Serum. 
In vitro Phagocytosis Assay 
Overnight cultures of S. aureus were normalized and grown for 100 min before 
collecting them by centrifugation. These cells were washed using 1X PBS and opsonized 
by incubating them with 10% orthologous human serum. Post opsonization, cells were 
collected by centrifugation and re-suspended in RPMI 1640 medium. Neutrophils and 
bacteria were mixed at a MOI of 1:100 and incubated at 37°C and 5% CO2. Samples 
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were collected every 15 min for serial dilution and plating on Todd-Hewitt Agar. 
Gentamicin (final concentration of 400 µg/ml) was added to kill the extracellular 
bacteria. Neutrophils were collected by centrifugation, washed with PBS, and lysed in 
37°C warm 0.02% Triton X containing PBS. This enables enumeration of the surviving 
intracellular bacteria only. Colonies were counted after 15 hours of incubation at 37°C 
and represented in a log plot as CFU/ml against time (minute).  
Neutrophil Activation Assay 
Neutrophils activation was assessed according to a modified version of the 
protocol described by Gouwy and group (Gouwy, Struyf, Catusse, Proost, & Van 
Damme, 2004). Briefly, post opsonization, cells were prepared similar to the 
phagocytosis assay, mixed with bacteria and incubated for 10 minutes at 37°C and 5% 
CO2. Samples were arrested by fixing them with 2% glutaraldehyde. Neutrophil 
activation was assessed by the change of shape using a scanning electron microscope. 
Scanning Electron Microscopy 
After fixation with 2% glutaraldehyde, samples were washed with PBS and 
serially dehydrated by consecutive incubations in 25%, 50%, 75%, 90%, and 100% 
ethanol and HDMS. Samples were mounted onto specimen mounts and sputter coated 
with platinum (5 mm).  Images were acquired ona FEI Quanta 200 Scanning Electron 
Microscopy (FEI Company, OR.) 
Detection of the Immune Evasion Cluster 
The immune evasion cluster (IEC) of USA300 and UAMS-1 was detected by 
polymerase chain reaction (PCR) using the primers described by van Wamel and group 
(van Wamel Rooijakkers, Ruyken, Van Kessel, & Van Strijp, 2006).  
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Chemotaxis Assay 
The Chemotaxis Assay will be conducted according the protocol described by 
Durr et al., 2006. Migarated PMNs were stained with BCECF AM 
(2′,7′‑bis‑(2‑carboxyethyl)‑5‑(and‑6)‑carboxyfluorescein- acetoxymethyl) and 
enumerated by flow cytometry.  
Clumping Factor Quantification Assay 
ClfA binds to both soluble and insoluble fibrinogen and this binding was assayed 
using fibrinogen as described by (Que et al., 2000). Briefly, two-fold serial dilutions of 1 
mg/ml of fibrinogen (100 µl) were tested with 20 µl of cells washed in ice cold 0.9M 
NaCl and resuspended in 1/10 of the initial volume in the same NaCl solution. Both 
strains were mixed with the fibrinogen dilutions and incubated at 4ºC for 24 hours. The 
wells were washed with 1X PBS thrice, fixed with 100% ethanol and stained with crystal 
violet. The plate was allowed to dry after washing off the excess dye. The wells were 
washed with 1X PBS. Hundred percent of alcohol was added to each well and allowed to 
stand for 10 min for the dye to release itself from the cells. The absorbance of the 
released dye was measured at 595 nm. 
Protease Assay 
Filter sterilized culture supernatants were collected from post exponentially 
growing wild type and mutant strains of USA300 LAC and UAMS-1. Azocasein (3 
mg/ml) prepared in Tris Buffered saline (pH 7.5) was added to the supernatant and 
incubated in the dark at 37°C. After overnight incubation, trichloroacetic acid (50%) was 
added to precipitate the un-degraded azocasein. Centrifugation separated the precipitate. 
Protease activity was assayed by measuring the absorbance (340 nm) of the supernatant. 
In order to quantify the metalloproteases, EGTA (1 mM) was employed. 
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Hemolytic Assay 
Hemolytic assay was conducted according to the protocol described in Chapter 
III. 
RNA Isolation and Real Time qPCR 
RNA was isolated according to the protocol described by Sambanthamoorthy, et 
al. (Sambanthamoorthy, Smeltzer, & Elasri, 2006). The primers used are described in 
Table 9. Gyrase (gyr) was used as an endogenous control. 
Table 9 
Primers used for RT-qPCR 
 
Gene 
 
Primer Sequence (5’ to 3’) 
 
Reference 
clfA FP 
clfA RP 
CCT GAT GAG CCT GGT GAA AT 
ATC GCT GCC AGA ATC TGA AC 
(Sambanthamoorthy, 
Smeltzer, & Elasri, 2006) 
chp FP 
chp RP 
ACCGTTTCCTACAAATGA 
TTCAGCAAGTGGTGTATTC 
(Burian, Wolz & Goerke, 
2010) 
scn FP 
scn RP 
TTGCCAACATCGAATGAA 
CATTGCTTTTTGACCTGAA 
(Burian, Wolz & Goerke, 
2010) 
map FP 
map RP 
AATAATAATGAAGCGTCTGC 
CCTACTTTCAAATCGANAAC 
(Burian, Wolz & Goerke, 
2010) 
sak FP 
sak RP 
TGTAGTCCCAGGTTTAATAGG 
CGCGAGTTATTTTGAACC 
(Burian, Wolz & Goerke, 
2010) 
spa FP 
spa RP 
AGA TGA CCC AAG CCA AAG TG 
GCT TTC GGT GCT TGA GAT TC 
(Sambanthamoorthy, 
Smeltzer, & Elasri, 2006) 
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Table 9 (continued). 
 
Gene 
 
Primer Sequence (5’ to 3’) 
 
Reference 
hla FP 
hla RP 
GAA AGG TAC CAT TGC TGG 
TCA 
AAG GCC AGG CTA AAC CAC TT 
(Sambanthamoorthy, 
Smeltzer, & Elasri, 2006) 
aur FP 
aur RP 
GCA CTT TAT CAC CAG CAG CA 
TTG ACC GCA TCA CTC TTT TG 
(Sambanthamoorthy, 
Smeltzer, & Elasri, 2006) 
gyr FP 
gyr RP 
CAT TGC CAG ATG TTC GTG AC 
CCG GTG TCA TAC CTT GTT CA 
(Sambanthamoorthy, 
Smeltzer, & Elasri, 2006) 
 
Western Blot 
Cells were collected at the appropriate growth phase and washed with PBS before 
lysing them with lysostaphin and glass beads. Lysates were loaded on SDS-PAGE gels 
and immunoblots were tested for protein A, using anti-Spa antibodies (Sigma-Aldrich). 
Defensin Susceptibility Assay 
Susceptibility to defensins was assessed as described by Jin et al. (2004). Briefly, 
cultures were grown in THB and normalized to an OD of 0.05. To these cultures Human 
Neutrophil Protein-1(HNP-1) and HNP – 2 (5 µg/ml) was added separately. Viability was 
tested by collecting samples after 6 hours of incubation at 37°C. Samples collected were 
serially diluted and plated on horse blood agar. Colonies were enumerated after 18 hours 
of incubation at 37°C. 
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Results 
msa is Required for Persistence and Dissemination of S. aureus 
Persistence and dissemination of the wild type and msa mutants of S. aureus 
strains were studied using a murine sepsis model. No difference was seen between the 
wild type and the msa mutants of LAC strains (Figure 21). On the other hand there was a 
decrease in bacterial load in the lungs of the mouse infected with the msa mutant of 
UAMS-1 compared to the wild type (Figure 22).  
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Figure 21. Bacterial load of wild type and mutant strains of S. aureus LAC strains in the 
various organs of the murine sepsis model. In these box and whisker graphs, the solid line 
is the median and the + is the mean. The boxes represent the interquartile range (IQR). 
No statistical significance seen (Mann Whitney test): P<0.05. 
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Table 10 
Statistical Significance by Mann Whitney test of LAC strains in the sepsis model 
 
Organ 
 
Significance by Mann Whitney test 
Lungs 0.362 
Kidneys 0.362 
Brain 0.356 
Heart 0.524 
Spleen 0.798 
Liver 0.700 
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Figure 22. Bacterial load of wild type and mutant strains of S. aureus UAMS-1 strains in 
the various organs of the murine sepsis model. In these box and whisker graphs, the solid 
line is the median and the + is the mean. The boxes represent the interquartile range 
(IQR). Statistical significance (Mann Whitney test) seen only in the case of Lungs: 
P<0.05. 
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Table 11 
Statistical Significance by Mann Whitney test of UAMS-1 strains in the sepsis model 
 
Organ 
 
Significance by Mann Whitney test 
Lungs 0.024 
Kidneys 0.670 
Brain 0.645 
Heart 0.362 
Spleen 0.210 
Liver 0.188 
 
Deletion of msa Influences Survival in Blood 
Mutant and wild type strains of USA300 LAC and UAMS-1 were tested for their 
ability to survive in gender pooled whole human blood. Mutation in USA300 LAC 
increased its ability to survive (Figure 23) while in UAMS-1 it decreased the survival in 
blood (Fig. 24).When comparing the wild types of the two strains of USA300 LAC and 
UAMS-1, clearly the osteomyelitis strain UAMS-1 survived better and multiplied more 
than the skin and the SSTI causing USA300 LAC. 
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Figure 23. Increased percentage survival of the msa mutants of S. aureus LAC strains in 
whole human gender-pooled blood compared to the wild type and complement strains. 
Deletion of the msa gene revealed increased percentage survival in the msa mutants of S. 
aureus LAC strains. 
 
 
Figure 24. Decreased percentage survival of the msa mutants of S. aureus UAMS-1 
strains in whole human gender-pooled blood compared to the wild type and complement 
strains. Deletion of the msa gene revealed decreased percentage survival in the msa 
mutants of S. aureus UAMS-1 strains. 
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Figure 25. Growth Curve of UAMS-1 strains showing no effect on the growth of UAMS-
1 strains on deleting the msa gene. 
 
 
Figure 26. Growth Curve of LAC strains showing no effect on the growth of LAC strains 
on deleting the msa gene. 
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Figure 27. Viability Assay of the strains S. aureus LAC and UAMS-1 showing no change 
in viability on deleting the msa gene. 
 
The effect of msa on growth and viability was also tested (Figure: 25-27). Neither 
strain showed a difference between the wild type and mutant. This, ruled out the 
possibility of a growth defect caused by the mutation and confirmed that the survival rate 
of the mutants in blood was influenced by the interactions of the bacteria with the 
components of the whole blood. In the presence of blood, the msa mutant of UAMS-1 
was unable to survive as well as the wild type or the strains of LAC either. These results 
suggest that msa plays an important role in determining clearance or persistence of S. 
aureus in the bloodstream of the host. However, this role was observed to differ across 
the two genetic backgrounds tested. 
msa Does Not Contribute to Preventing Chemotaxis 
Chemotaxis assay using the supernatant of strains of LAC and UAMS-1 did not 
reveal any significant difference in attracting PMNs as seen in Figure 28. Thus, we have 
no evidence of msa preventing chemotaxis.  
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Figure 28. Percentage of PMN migrating in response to the supernatant of the strains of 
LAC and UAMS-1. No significant change was observed in the chemotaxis of neutrophils 
in response to the supernantants of S. aureus strains. 
 
msa Prevents Neutrophil Activation 
Neutrophils are spherical in shape until they are activated by the presence of a 
pathogen, then they branch out to form pseudopodia and invagination cups to engulf the 
pathogen. After incubating the neutrophils for 10 minutes with the strains of LAC and 
UAMS-1, only the neutrophils in the presence of msa mutants of UAMS-1 showed 
extensive branching, and the UAMS-1 complements showed shorter branching. Thus, 
based on the morphological change, we report that the mutants increased the activation of 
neutrophils. All other strains retained their spherical shape. 
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Figure 29 a. Scanning Electron Microscopy showing the spherical neutrophils in the 
absence of S. aureus. Neutrophils in the absence of S. aureus were used as a negative 
control to reveal the spherical shape of inactive neutrophils. 
 
.  
Figure 29 b. Scanning Electron Microscopy of neutrophils showing no change in shape in 
the presence of S. aureus LAC strains 
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Figure 29 c. Scanning Electron Microscopy of neutrophils comparing the extent of 
branching of neutrophils in the presence of UAMS-1 strains. 
 
msa contributes to the outcome of PMN attack 
Neutrophils are the primary components of the innate immune system whose 
rapid, un-biased response clears pathogens from the host system. We tested the effect of 
this non-specific clearance by neutrophils on the mutant and wild type strains of USA300 
LAC and UAMS-1 on engulfing the cells (Figure 30). The mutant in UAMS-1 showed 
decreased intracellular counts when rescued from the neutrophils (Figure 32). In some 
experimental runs (not shown here), the UAMS-1 mutant showed zero CFUs reflecting 
death and eradication of the mutant by the neutrophils. Thus, mutation of msa in the 
UAMS-1 strains somehow made these strains susceptible to immunological clearance by 
neutrophils compared to the wild type UAMS-1. The same mutation in LAC strains 
showed no change in the intracellular survival (Figure 31). The mutant and wild type 
strains of USA300 LAC survived equally well when exposed to phagocytosis by human 
neutrophils. 
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A B 
Figure 30. TEM image showing the intracellular presence of S. aureus (A) LAC strains 
and (B) UAMS-1 in human neutrophils.  
 
 
Figure 31. Phagocytosis Survival Assay of S. aureus LAC strains showing no difference 
in intracellular survival on deleting the msa gene. 
 
 
Figure 32. Phagocytosis Survival Assay of S. aureus UAMS-1 strains showing a decrease 
in intracellular survival on deleting the msa gene 
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msa regulates the Immune Evasion Cluster 
USA300 strains of S. aureus were observed to carry bacteriophage-encoded 
immune evasion cluster (IEC) type B (Highlander et al., 2007). The IEC type in UAMS-1 
was unknown. Based on the classification described by van Wamel (2006) and our results 
from the detection of the sea, sak, chp and scn by PCR (Figure 33), we report UAMS-1 to 
be IEC type A. RT-qPCR analysis showed that deletion of msa reduced the expression of 
scn and sak in UAMS-1 (Table 12). Thus, we show that msa regulates IEC, a mobile 
genetic element of UAMS-1 strains. 
 
Figure 33. Detection of sea, sak, chp and scn genes in S. aureus LAC wild type (1), 
LACΔmsa (2), LAC complement (3), UAMS-1 (4), UAMS-1Δmsa (5) and UAMS-1 
Comp (6). S. aureus LAC strains bear the IEC type A and UAMS-1 the IEC type B. 
 
msa Regulates Phagocytic Evasion Factors 
Transcript analysis revealed several evasion factors to be regulated by the msa 
gene (Table 12) and, interestingly, the regulation differed between the staphylococcal 
strains of LAC and UAMS-1. In LAC, deletion of msa resulted in decreased expression 
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of clfA and increased expression of aur. In UAMS-1, there was a decrease in expression 
of clfA, aur, scn, and spa.  
Table 12 
Relative fold change in the expression of the genes required for phagocytic evasion on 
deleting the msa gene. 
 
Gene 
 
LAC 
 
UAMS-1 
chp - 2.56¥ 3.23 
scn - 1.36 - 6.06¥ 
sak 1.89 - 5.5¥ 
clfA - 10.96¥ - 41.75¥ 
spa 1.56 - 4.04 
aur 8.12¥ - 4.44¥ 
hla - 0.6 * 
sarA - 6.54¥ - 6.03¥ 
agrB -2.52¥ - 6.28¥ 
Note. ¥ - p-value less than 0.05; * - Naturally mutated. 
msa Prevents Opsonization 
We tested several factors previously known to be employed by S. aureus to 
prevent opsonization and/or opsonophagocytosis to study if msa regulated any of them. 
The factors we tested were ClfA (Josefsson, Hartford, O’Brien, Patti, & Foster, 2001; 
Palmqvist et al., 2004, McAdow et al., 2011), protein A (Peterson, Verhoef, Sabath, & 
Quie, 1977; Gemmell, Tree, Patel, O’Reilly, & Foster, 1991; Palmqvist, Foster, 
Tarkowski, & Josefsson, 2002; Patel, Nowlan, Weavers, & Foster, 1987; Uhlen et al., 
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1984), and capsular proteins (Nilsson et al., 1997; Thakker, Park, Carey, & Lee, 1998;). 
The regulatory effect of msa on the expression of these factors was studied by analyzing 
the transcripts and assaying for each of these factors. 
0
2
4
6
8
10
12
14
16
A
b
so
rb
an
ce
 a
t 
5
9
5
 n
m
Concentration of Fibrinogen (mg/ml)
LAC
msa
Comp
 
Figure 34. Quantification of ClfA levels based on the ability to bind to fibrinogen 
revealed reduced ClfA levels in the mutants of S. aureus LAC 
 
Owing to the ability of ClfA to bind to fibrinogen, levels of surface exposed ClfA 
was measured by quantifying the cells bound to the range of fibrinogen concentrations. 
Deletion of msa in LAC and UAMS-1 showed a significant drop in fibrinogen-bound 
cells (Figure 34 and 35) indicating reduced levels of surface associated ClfA proteins. 
This observation was further supported by the reduced transcription of clfA seen in 
transcript analysis (Table 12). Thus, we have evidence that the msa gene is required for 
preventing opsonization by maintaining the levels of ClfA in S. aureus. Analyzing the spa 
transcripts and Spa protein levels using western blots showed no difference between wild 
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type and msa mutant suggesting that in both LAC and UAMS-1 strains (Figure 36) msa 
does not regulate the protein A. 
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Figure 35. Quantification of ClfA levels based on the ability to bind to fibrinogen 
revealed reduced ClfA levels in the mutants of S. aureus UAMS-1. 
 
 
Figure 36. Western Blot with anti-Spa antibodies showing no difference in Spa levels 
between the wild type and mutant strains of LAC and UAMS-1. 
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When testing staphylokinase transcript levels in mutant and wild type strains, 
there was a -5.5 decrease in sak expression in UAMS-1 strains whereas in USA300 LAC 
there was no significant increase or decrease in sak levels (Table 12).  
Taken together, these results indicate that of the factors tested msa regulates 
evasion of opsonization by regulating the clfA levels. 
msa Does Not Aid in Escaping from the Phagocyte 
Strains of S. aureus LAC express the α-hemolysin (encoded by hla) when 
phagocytized which aids in the escape of the bacteria by the lysis of PMN (Kubica et al., 
2008, Pang et al., 2010). Hemolysin expression and toxicity was assayed. Cells were 
collected at an early stationary phase of about OD600 nm = 3.5 to analyze the transcript 
levels. Deletion of msa in LAC strains showed no significant change in hla transcription. 
The supernatant collected from the same time point was used for hemolytic assay, which 
showed no difference in activity between the wild type and mutant (Figure 37). UAMS-1 
has an inherent mutation in the hla gene, which rules out the possible contribution it 
could have to lysis and phagocytic escape (Weiss et al., 2009). 
 
Figure 37. Hemolytic activity showing no difference between the mutant and wild type 
strains of S. aureus LAC strains 
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msa Contributes to the Intracellular Phagocytic Survival 
Deletion of msa in S. aureus LAC increased the levels of extracellular proteases 
(Figure 38). Differential assaying to identify individual classes of proteases revealed 
aureolysin to be the most abundantly increased on deleting the msa gene. Supporting this 
finding, RT-qPCR also revealed an increase in aur expression (Table 12) on deleting the 
msa gene. In UAMS-1 deletion of msa, showed reduced transcripts (Table 12). This 
decrease in protease activity although was not seen in the protease assay (Figure 39). This 
suggested that msa contributes to regulation of intracellular survival via the protease 
levels although the extent of influence on the intracellular survival differs among strains 
of S. aureus. 
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Figure 38. Protease activity of S. aureus LAC strains using azocasein as a substrate 
showed increased protease activity on deleting the msa gene in S. aureus LAC strains. 
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Figure 39. Protease activity of S. aureus UAMS-1 strains using azocasein as a substrate 
showed no difference on deleting the msa gene in S. aureus LAC strains. 
As shown earlier, the deletion of the msa gene decreased transcript levels of 
staphylokinase by a – 5.5 fold in UAMS-1 but did not influence the same in LAC strains 
(Table 12). Jin et al (2004), showed the neutralizing effect of the staphylokinase on 
human defensin peptides. Hence, the susceptibility of the strains LAC and UAMS-1 were 
assessed using human defensing peptides. Mutants of msa did not show an increase or 
decrease in susceptibility to HNP (Figure 40-41). 
 
Figure 40. Mutation of msa in LAC did not influence susceptibility of S. aureus LAC 
strains to HNP-1. 
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Figure 41. Mutation of msa in UAMS-1 did not influence susceptibility of S. aureus 
UAMS-1 strains to HNP-1. 
 
Discussion 
Most invasive infections of S. aureus have been observed to be accompanied by 
sepsis (Liu et al., 2011). Klevens et al., in 2008 reported that less than half of the sepsis 
patients under intensive care succumbed to death (Klevens et al., 2008). Infection in the 
blood provides a convenient route of infection dissemination of bacteria like S. aureus. In 
order to disseminate to and colonize the various organs of the host, S. aureus should be 
able to share the path of the hematogenous route with phagocytes, complement proteins, 
and other members of the immune system that are constantly clearing the host system of 
such foreign entities. Thus, in order to study the role of msa in host persistence and 
infection dissemination a sepsis model was employed. 
Organs have their own organ-specific immune factors that defend the organs from 
an infection. The liver plays an important role in bacterial clearance (Benacerraf, 
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Sebestyen, & Schlossman, 1959; Brandborg & Goldman, 1990; Mackaness, 1962; Mims, 
1987). When septicemic blood flows through the liver, the bacteria adhere on to the 
hepatocytes via an interaction between their carbohydrate receptors and lectins 
respectively. Immigrant polymorphonuclear neutrophils (PMNs) attracted to these 
hepatocyte bound bacteria engulf and phagocytize them (Ofek & Sharon, 1984; Perry & 
Ofek, 1984, Perry, Keisari, & Ofek, 1985). PMNs are important and abundant players of 
the innate immune system that prevent the propagation of bacteria in the liver (Gregory et 
al., 1996). Spleen also plays an important role in bacterial clearance and detoxification of 
toxins (Altamura et al., 2001). Phagocytosis is one of the most important modes of 
bacterial clearance, which is accomplished by the splenic macrophages, marginal zone 
macrophages of the spleen, and alveolar macrophages of the lungs. The spleen receives 
200-300ml/min/100-150g organ of blood flow in human and at the site of its red pulp it 
purifies the blood of old and damaged RBCs along with any cell debris (Timens, 1991). 
Blood also flows through the B- and T-lymphocyte containing white pulp of the spleen 
and exposes the antigens carried by the blood to antibody production. These antibodies 
aid in opsonization of bacteria and its subsequent clearance from the blood (van den 
Dobbelsteen et al., 1993).  
The murine sepsis model used to study the regulation of infection dissemination 
by msa showed varying results in the two strains used: LAC and UAMS-1. Deleting the 
msa gene in the genetic background of LAC did not alter the dissemination of infection 
via the blood stream to the organs. Bacterial load in the lungs although was reduced in 
the murine models infected with the mutant strains of UAMS-1as compared to the wild 
type. This finding suggests several possibilities. Firstly, in the strains of LAC the 
regulation of infection dissemination by the msa gene is overpowered by a stronger 
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global regulator or this regulator may not be completely under the regulation of the msa 
gene. In UAMS-1 the same possibilities could be the case although the extent of the 
influence of the regulation by msa could be more than that seen in LAC strains. Second 
and most importantly, the sepsis model is that a murine organism. Hence, the findings of 
the murine sepsis model may not truly reflect the true behavior of the strains, as the 
virulence factors of S. aureus are human specific (Rooijakkers et al., 2005c; Serruto et 
al., 2010). 
The blood stream, which is the carrier of the infection, also harbors the factors 
that kill microbes. We assessed the ability of the wild type and mutants to survive in 
gender-pooled whole human blood. When the strains of S.aureus were co-incubated with 
whole human blood, the mutant of LAC survived better than the wild type (Figure 23), 
while in the case of UAMS-1, the wild type survived better than the mutant (Figure 24). 
These results were in agreement with the results obtained from the phagocytosis survival 
assay (Figure 31 and 32). 
Neutrophils in the presence of chemotactic factors undergo changes in shape like 
blebbing and branching of extensions. According to Guowy et al., (2004), the 
chemotactic factor interleukin -8 was responsible for blebbing while IL-8 and monocyte 
chemotactic protein – 3 (MCP-3) was responsible for the extensions from the neutrophils. 
Neutrophils exposed to S. aureus strains for 10 minutes showed blebbing in all UAMS-1 
strains but the highest level of extensions were observed in UAMS-1 mutants. This 
indicated that UAMS-1 mutants induced the highest levels of chemotactic factors. 
Comparing our observations with that of Guowy et al., (2004) we suggest that these 
factors could be IL-8 and MCP-3. Although we observed increased chemotactic response 
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from the neutrophils exposed to UAMS-1 mutants, the chemotaxis assay did not show an 
increase in chemotaxis as compared to the wild type.  
In the phagocytosis survival assay, the mutant in UAMS-1 showed increased 
susceptibility to phagocytosis (Figure 32), but in LAC the mutation showed no change in 
the susceptibility to phagocytosis. Thus, we have evidence of the regulatory influence of 
the msa gene in immunological clearance by neutrophils and persistence in the 
bloodstream. This observation also indicates the importance of the msa gene in 
combating the attack of the innate immune system on S. aureus. 
The susceptibility or resistance observed in the blood and phagocytosis assay, 
however, was not in congruence with the results of the sepsis model. Decreased bacterial 
counts were observed only in the lungs when infected with UAMS-1 mutants. There was 
no significant decrease in survivors of the UAMS-1 mutants in the other organs that 
utilize phagocytosis for clearing the blood supplied microbes. This we assume is due to 
the high number of phagocytes and efficient organ-specific phagocytosis that clears the 
wild type and the mutant without any significant discrimination. Another important factor 
to take into consideration is that the animal model used was that of a murine species. 
These results may not coincide with the results obtained from the experiments conducted 
with blood and neutrophils obtained from humans. 
Sambanthamoorthy et al. in 2006 showed that the msa gene regulated other global 
regulators like sarA and agr (Sambanthamoorthy, Smeltzer, & Elasri, 2006). When 
analyzing the effect of the msa mutation on the expression of these global regulators in 
the strains of LAC, RNA III levels decreased to a smaller extent (- 2.52 fold) as 
compared to the decrease seen in the UAMS-1 strains (- 6.5 fold). Intracellular survival 
and escape of the S. aureus USA300 strains from the PMN is strongly regulated by the 
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agr system (Pang et al., 2010). Thus, there is a possibility that the down-regulation of 
RNA III observed in LAC on deleting the msa gene, may not have reduced the agr levels 
to a degree that will make the LAC strains susceptible to immunological clearance. Thus, 
the msa mutant in LAC retained the ability to survive undeterred in the host. This 
reasoning could explain the findings of the animal model (ignoring the difference 
between organisms), blood survival, and neutrophil assays. 
On the other hand, in UAMS-1 there have been no previous studies indicating the 
key global regulator involved in intracellular survival in PMNs. The results obtained in 
our study, revealing increased susceptibility and clearance in the phagocytosis and blood 
survival assays, indicate a possibility of agr also being involved in PMN survival of 
UAMS-1 strains. Since, the mutation of msa reduced the RNAIII levels in UAMS-1 more 
than it did in LAC, we could assume that this is the reason why mutation of msa 
weakened the strain of UAMS-1 but not LAC.  
The msa gene also regulates the sarA levels in S. aureus (Sambanthamoorthy, 
Smeltzer, & Elasri, 2006). Deleting the msa gene reduced the sarA levels to a -6.54 and a 
-6.03 fold in the LAC and UAMS-1 strains. Owing to the fact that in UAMS-1, the key 
regulator required for PMN survival has not been shown yet, the 6 fold reduction seen in 
sarA levels could also contribute to PMN survival as sarA is an important global 
regulator. Until the key regulator of UAMS-1 required for surviving a PMN attack is 
identified, we cannot safely place our assumptions on the regulation of msa through by 
either agr or the sarA systems. 
The staphylococcal feat of phagocytic evasion can be divided into four levels: 
prevention of chemotaxis, prevention of opsonization, phagocytic escape (post-
engulfment), and intracellular survival (Figure 42). Testing for the various factors 
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contributing to the illustrated levels of preventing phagocytosis, msa was observed to 
regulate the levels of clumping factor A (ClfA), staphylococcal complement inhibitor 
(SCIN), staphylokinase (Sak), protein A (Spa), and aureolysin (Aur) in the 
staphylococcal strains. However, depending on the strain, the combination of factors 
influenced by the gene regulation by msa differs. 
 
Figure 4.2. Schematic representation of the four levels of phagocytic evasion by S. 
aureus. Staphylococcal factors of immune evasion that contribute to the various stages 
are also enlisted in this representation. 
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In the strains of LAC, deletion of the msa gene decreased the ClfA levels and 
increased the Aur levels, which seems conducive to the resistance to immunological 
clearance. The decrease in the ClfA levels could have increased the probability of 
opsonophagocytosis. Phagocytic uptake appears to be instrumental to resisting the 
immune system as the staphylococcal cells, once engulfed, have the ability to survive 
within the phagocyte owing to the increased levels of aureolysin. Thus, the mutation in 
LAC provided a safe haven from the non-phagocytic and phagocytic attacks of the 
immune system. In addition, the intracellular survival in the circulating neutrophils could 
have also served as a vehicle of dissemination. These assumptions based on the ClfA and 
Aur levels explain the undeterred survival of the mutants of LAC in the sepsis model, 
blood survival, and phagocytosis assays. Thus, msa in the strains of LAC is required for 
maintaining the levels of ClfA and Aur to evade the innate immune system. 
In UAMS-1, deleting the msa gene decreased the transcription of SCIN, ClfA, 
Spa, Sak and Aur. Assaying for ClfA levels clearly showed a decrease in surface 
associated levels of ClfA on mutating the msa gene. However, phenotypic assays for 
studying levels of Spa and Aur showed no difference. We, thus, suggest that the 
significant reduction in clfA levels in the mutant could have contributed to the increased 
probability of opsonophagocytosis. However, unlike in the case of the msa mutant in 
LAC strains, phagocytized mutants of UAMS-1 do not have high levels of Aur or an 
undeterred level of Sak that support intracellular survival in PMN. Thus, the mutant of 
msa in UAMS-1 is susceptible to clearance by the neutrophils. This, we propose, could 
have contributed to the increased susceptibility seen in blood survival and phagocytosis 
assays. Reduced transcription of SCIN was observed in the mutants of UAMS-1, 
although no difference was observed in the chemotaxis assay. Thus, in UAMS-1 the 
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regulation by the msa gene is required for upregulating the clfA, spa, sak, aur and scn 
levels to resist the innate immune system and to disseminate via intracellular survival in 
neutrophils. 
Thus, we have evidence of the role of the msa gene in the regulatory network 
governing the susceptibility or resistance to immunological clearance and exploitation of 
PMNs for infection dissemination-a remarkable characteristic of S. aureus. The extent of 
regulation by the msa gene, however, seems to differ across strains. In addition, we report 
for the first time the regulatory influence of msa on the IEC, a mobile genetic element. 
There are several factors that we suggest could hold a plausible explanation to the strain-
dependent behavior of msa. Some of them include (a) the sequence variation of a gene 
(virulence factor or gene regulator) across the strains of S. aureus that could influence the 
regulatory effect of msa on that particular gene, (b) inherent single nucleotide 
polymorphisms that could render a gene inactive or weak, (c) acquisition of mobile 
genetic elements, and (d) redundancy of virulence factors that could mask the effect of 
msa mutation as seen in the case of LAC. 
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CHAPTER V 
REGULATION OF PROTEASES BY MSA IN BIOFILM  
AND NON-BIOFILM CONDITIONS 
Abstract 
Staphylococcal biofilms have been a growing problem in the healthcare sector 
due to the resistance to antimicrobial treatment options, repetitive surgical interventions 
and containment of infection. Detachment of cells from a biofilm not only plays an 
important role in biofilm development, but also in the dissemination of infection. The 
msa gene of S. aureus has been previously observed to down-regulate proteases. 
Extracellular proteases of S. aureus are very important virulence factors that play an 
important role in several stages of the staphylococcal infection and especially in 
dissemination. Hence, we studied the effect of msa on the staphylococcal proteases of the 
community-acquired MRSA strain USA300. Interestingly, deletion of msa increased 
protease levels when the cells were growing under non-biofilm, planktonic conditions, 
but in biofilm conditions the mutation had no effect on the proteases. This revealed an 
environment-dependent variation of the regulation by the msa gene. Thus, the msa gene 
might play a more significant role in non-biofilm infections than in biofilm infections of 
S. aureus. 
Introduction 
Proteases are extracellular enzymes released by Staphylococcus aureus during the 
post exponential phase of growth. S. aureus produces three important classes of proteases 
namely metalloprotease (Aureolysin), serine protease (V8 protease) and the cysteine or 
thiol proteases (Arvidson, 2000). 
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These proteases are translated as proenzymes, which are cleaved in order to 
activate them. The ssp operon contains sspA, sspB, and sspC. Aureolysin cleaves the 
proenzyme form of serine protease (Drapeau, 1978).The SspA thus active in turn is 
required for cleavage and activation of SspB, a cysteine protease (Karlsson & Arvidson, 
2002; Rice, Peralta,Bast, deAzavedo, & McGavin, 2001). SspC (also known as 
staphostatin B) formed is a specific inhibitor of aur. This ssp operon is positively 
regulated by agr and negatively regulated by σB and the regulator sarA (Blevins et al., 
2002; Karlsson & Arvidson, 2002; Shaw et al., 2004; Tsang, Cassat, Shaw, Beenken, & 
Smeltzer, 2008). These serine proteases play important roles in processing cell surface 
proteins like fibronectin binding protein (FnBP) and protein A (Karlsson & Arvidson, 
2002; McGavin, Zahradka, Rice, & Scott, 1997) and in immune evasion (Burlak et al., 
2007). Several such surface proteins, namely the biofilm-associated protein Bap 
(Cucarella et al., 2001), protein A (Merino et al., 2009), FnBP (O’Neill et al., 2008), and 
SasG (Corrigan, Rigby, Handley, & Foster, 2007) play vital roles in biofilm formation. 
 
Figure 43. Stages of biofilm development of S. aureus. S. aureus form biofilms through 
the stages of attachment onto a surface, growth and formation of biofilm towers and 
detachment of biofilm (Dirckx & Stoodley, 2003). 
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Analyzing the constituents of biofilms, several studies showed that along with the 
conglomeration of cells, biofilms had an extracellular matrix consisting of proteins, DNA 
(Rice et al., 2007), and/or polysaccharide intercellular adhesion PIA/PNAG encoded by 
the icaADBC operon (Cramton, Gerke, Schnell, Nichols, & Gotz, 1999). To weaken 
these recalcitrant biofilms, degrading agents specific for these individual constituents 
were added (Boles & Horswill, 2008; Izano, Amarante, Kher, & Kaplan, 2008; Mann et 
al., 2009). These biofilms formed by several clinical isolates have been observed to be 
polysaccharide dependent or even independent (Boles, Thoendel, Roth, & Horswill, 
2010; Lauderdale, Boles, Cheung, & Horswill, 2009; Lauderdale, Boles, Morcuende, & 
Horswill, 2010; O’Neill et al., 2007).  
As seen previously in S. aureus COL, deletion of the msa gene in the new and 
virulently emerging strain USA300 LAC increased the protease levels 
(Sambanthamoorthy, Smeltzer, & Elasri, 2006). Deletion of the msa gene was also 
observed to weaken the biofilm formed by S. aureus COL (Sambanthamoorthy, 
Schwartz, Nagarajan, & Elasri, 2008). This led us to question if the weakening of 
biofilms formed by the msa mutant was due to the increased protease levels. Here, in this 
study, we tested the effect of protease regulation by the msa gene in biofilm and non-
biofilm conditions, to understand the relationship of msa and proteases. 
Materials and Methods 
Protease Assay 
Protease activity was quantified as described in Chapter III. In order to quantify 
the individual classes of proteases, the respective inhibitors were added. The protease 
activity for each class was assessed by adding specific protease inhibitors. EGTA (1 
mM), PMSF (200 µM), and E-64 or 20 µM L-trans-epoxy-succinyl-leucylamido (4-
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guanidino) butane was employed to inhibit metalloproteases, serine proteases, and thiol 
proteases, respectively. Proteases from biofilm effluents were also assessed similarly. 
RNA Isolation and Real-time PCR 
RNA was isolated from cells grown in planktonic and biofilms conditions using 
Rneasy kit (Qiagen Inc.). Transcript levels of the proteases were determined using real-
time quantitative PCR (RT-qPCR) with the primers described in Table 13. As an 
endogenous control gyr (gyrase) primers were used. 
Table 13 
Primers for RT-qPCR 
 
Gene 
 
Primer Sequence (5’ to 3’) 
 
Reference 
aur FP 
aur RP 
GCA CTT TAT CAC CAG CAG CA 
TTG ACC GCA TCA CTC TTT TG 
(Sambanthamoorthy, 
Smeltzer, & Elasri, 2006) 
ssp FP 
ssp RP 
TCA AGC AAA CAG CAA ACA CC 
TTT GCG TGT TCA CGT TGT TC 
(Sambanthamoorthy, 
Smeltzer, & Elasri, 2006) 
gyr FP 
gyr RP 
CAT TGC CAG ATG TTC GTG AC 
CCG GTG TCA TAC CTT GTT CA 
(Sambanthamoorthy, 
Smeltzer, & Elasri, 2006) 
 
Biofilm Detachment Assay 
Biofilms were grown in flow cells (Figure 44) following the methods described 
by Beenken, Blevins, & Smeltzer, (2003) and Beenken et al. (2004). Briefly, microtiter 
plates (Thermo Fisher Scientific Inc.) or flow cells (Stovall Life Science Inc.) were 
coated with human plasma and incubated at 4ºC overnight before inoculating the biofilm 
systems. Inoculums were prepared by normalizing the overnight cultures and added or 
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injected into the microtiter plate and flow cell respectively. Incubation was conducted at 
37ºC. Flow cells were pumped with TSB (supplemented with NaCl and glucose) at a flow 
rate of 0.5 ml/min (Figure 44). Samples were collected periodically and analyzed for 
protease activity and detachment.  
Effluents from flow cells were collected, serially diluted, and plated on TSA 
plates to enumerate the cells and, thus, determine the rate of detachment of biofilms cells. 
For quantifying protease activity, effluents were filter sterilized and subjected to the 
protease assay as described above. 
 
Figure 44. Flow cell set up employed for in vitro growth of biofilms of S. aureus. This 
set up consists of media pumped into the flow cell system using a peristaltic pump, a flow 
cell unit for the growth of biofilms, and a waste container. 
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Results 
msa Does Not Contribute to Biofilm Detachment 
Deletion of the msa gene did not affect the detachment of biofilm cells as seen in 
Figure 45. The number of cells detaching from the biofilms of wild type and mutant were 
equal at all the time points tested. This also revealed that the detached cells were all 
viable and hence the degree of metastatic infection was not influenced by the msa gene. 
 
Figure 45. Biofilm Detachment Assay showing no difference in biofilm detachment on 
deleting the msa gene from S. aureus LAC strains.  
 
Differential Regulation of Proteases 
Deletion of the msa gene increased the protease levels as observed by the protease 
assay (Figure 46) and the transcript analysis (Table 14). Clearly, this indicates the vital 
role of msa in maintaining the protease levels in S. aureus LAC strains. However, when 
the very same strains were grown under biofilm conditions, the deletion of the msa gene 
did not increase protease levels (Figure 46 and Table 14-16). Deletion of msa showed no 
change in the transcript levels of proteases in cells of the biofilms and that of the 
detaching cells. 
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Figure 46. Protease activity of non-biofilm cells of S. aureus LAC strains using 
azocasein. Individual classes of proteases were assessed by the addition of specific 
inhibitors to the sample . Serine protease was inhibited by PMSF, aureolysin by EGTA 
and cysteine protease by E-64. 
 
Table 14 
Relative Expression of proteases  
 
Gene 
 
Class of Proteases 
 
Fold Change 
aur  Metalloprotease 8.12 
ssp Serine Protease and Cysteine Protease 
(Co-transcribed) 
8.28 
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Figure 47. Protease Activity of the biofilm effluents of LAC strains of S. aureus 
Table 15 
Relative Expression of proteases in 50 hr mature biofilm.  
 
Gene 
 
Class of Proteases 
 
Fold Change 
aur  Metalloprotease 1.15 
ssp Serine Protease and Cysteine Protease 
(Co-transcribed) 
1.17 
 
Table 16 
Relative Expression of proteases in detached cells from 50 hr mature biofilm.  
 
Gene 
 
Class of Proteases 
 
Fold Change 
aur  Metalloprotease -1.07 
ssp Serine Protease and Cysteine Protease 
(Co-transcribed) 
1.26 
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Discussion 
Proteases play a very vital role in the virulence of S. aureus. They are not only 
virulence factors by themselves but also agents of regulation. In this work, it is evident 
that msa regulates these proteases, as deletion of the msa gene increased the overall 
protease activity and the transcript levels of aureolysin and serine proteases. Three 
classes of proteases were individually quantified to study the role of msa on each of them.  
The msa gene as seen in the detachment assay does not regulate the detachment of 
biofilms of LAC strains. Our observations have shown that under the biofilm conditions, 
the protease levels did not increase on deleting the msa gene, suggesting that although 
msa regulates proteases, under biofilm conditions the scenario of regulation might be 
different. The msa gene may not have control over proteases under biofilm conditions 
and/or there is another regulating factor that controls and maintains the protease 
production under biofilm conditions. This regulator may or may not be under the 
regulation of the msa gene. Clearly, the regulation of proteases under biofilms seems 
more complex than it appears under non-biofilm conditions. If proteases played a role in 
biofilm detachment in LAC strains, it would have possibly hinted at the constituents of 
the biofilms formed by LAC to be proteinaceous. At this point, we have no evidence of 
the nature of the constituents of the biofilms formed by the staphylococcal strains of 
LAC. 
The effects of the regulation by the msa gene seem to be influenced by the 
environment in which the staphylococcal cells are present. This could explain why we see 
an effect on the protease regulation in non-biofilm (planktonic) cells and not in cells of 
the biofilm. Thus, we conclude that the msa gene regulates proteases and might be 
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important in non-biofilm infections, but in biofilm infections the msa gene might be over-
powered or insignificant in regulating the proteases. 
 84 
 
 
APPENDIX 
IRB APPROVAL LETTER 
 
 
 85 
 
 
REFERENCES 
Adcock, P.M., Pastor, P., Medley, F., Patterson, J.E., & Murphy, T.V. (1998). 
Methicillin-resistant Staphylococcus aureus in two child care centers. Journal of 
Infectious Diseases, 178(2), 577-580. 
Alberti, C., Brun-Buisson, C., Burchardi, H., Martin, C., Goodman, S., Artigas, A., 
Sicignano, A., . . . Le Gall, R. (2002). Epidemiology of sepsis and infection in 
ICU patients from an international multicentre cohort study. Intensive Care 
Medicine, 28, 108-121. 
Altamura, M., Caradonna, L., Amati, L., Pellegrino, N.M., Urgesi, G., & Miniello, S. 
(2001). Splenectomy and sepsis: the role of the spleen in the immune-mediated 
bacterial clearance. Immunopharmacology and Immunotoxicology, 23, 153-161. 
Arvidson, S. (2000). Extracellular enzymes. In Gram-Positive Pathogens, 379-385. 
Edited by V. A. Fischetti. Washington, DC: American Society for Microbiology. 
Angus, D. C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J., & Pinsky, 
M.R. (2001). Epidemiology of severe sepsis in the United States: analysis of 
incidence, outcome, and associated costs of care. Critical Care Medicine, 29, 
1303-1310. 
Antimicrobe. (2010) Antimicrobe. Retreived from http://www.antimicrobe.org/ 
new/printout/e12printout/e12type.htm. 
Bae, T., & Schneewind. O., (2006). Allelic replacement in Staphylococcus aureus with 
inducible counter-selection. Plasmid, 55, 58-63. 
Bayer, A. S., Sullam, P.M., Ramos, M., Li, C., Cheung, A.L., & Yeaman, M.R. (1995). 
Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent 
 86 
 
 
mechanism which is independent of principal platelet glycoprotein IIb/IIIa 
fibrinogen-binding domains. Infection and Immunity, 63, 3634-3641. 
Bayer, M.G., Heinrichs, J.H., & Cheung, A.L. (1996). The molecular architecture of the 
sar locus in Staphylococcus aureus. Journal of Bacteriology, 178, 4563-4570. 
Bayer, A.S., Ramos, M.D., Menzies, B.E., Yeaman, M.R., Shen, A.J., & Cheung, A.L. 
(1997). Hyperproduction of alpha-toxin by Staphylococcus aureus results in 
paradoxically reduced virulence in experimental endocarditis: a host defense role 
for platelet microbicidal proteins. Infection and Immunity, 65(11), 4652-4660. 
Beenken, K.E., Blevins, J.S., & Smeltzer, M.S. (2003). Mutation of sarA in 
Staphylococcus aureus limits biofilm formation. Infection and Immunity, 71(7), 
4206-4211. 
Beenken, K.E., Dunman, P.M., McAleese, F., Macapagal, D., Murphy, E., Projan, S.J., 
Blevins, J.S., & Smeltzer, M.S. (2004). Global gene expression in Staphylococcus 
aureus biofilms. Journal of Bacteriology, 186(14), 4665-4684. 
Begier, E.M., Frenette, K., Barrett, N.L., Mshar, P., Petit, S., Boxrud DJ, … Hadler, JL; 
Connecticut Bioterrorism Field Epidemiology Response Team, (2004). A high 
morbidity outbreak of methicillin-resistant Staphylococcus aureus among players 
on a college football team, facilitated by cosmetic body shaving and turf burns. 
Clinical Infectious Diseases, 39(10), 1446-1453. 
Benacerraf, B., Sebestyen, M., & Schlossman, S. (1959). A quantitative study of kinetics 
of blood clearance of P32 – labeled Escherichia coli and staphylococci by the 
reticuloendothelial system. Journal of Experimental Medicine, 110, 27. 
Benito, Y., Kolb, F.A., Romby, P., Lina, G., Etienne, J., & Vandenesch F. (2000). 
Probing the structure of RNAIII, the Staphylococcus aureus agr regulatory RNA, 
 87 
 
 
and identification of the RNA domain involved in repression of protein A 
expression. RNA, 6, 668-679. 
Bhakdi, S., Muhly, M., Korom, S., & Hugo, F. (1989). Release of interleukin-1 beta 
associated with potent cytocidal action of staphylococcal alpha-toxin on human 
monocytes, Infection and Immunity, 57, 3512-3519. 
Bhakdi, S., & Tranum-Jensen, J. (1991). Alpha-toxin of Staphylococcus aureus. 
Microbiological Reviews, 55, 733-751. 
Bhakdi, S., Muhl, Y., Mannhardt, U., Hugo, F., Klapettek, K., Mueller-Eckhardt, C., & 
Roka, L. (1988). Staphylococcal α toxin promotes blood coagulation via attack on 
human platelets. Journal of Experimental Medicine, 168, 527-542. 
Bischoff, M., Dunman, P., Kormanec, J., Macapagal, D., Murphy, E., Mounts, W., … 
Projan, S., (2004). Microarray-based analysis of the Staphylococcus aureus σB 
regulon. Journal of Bacteriology, 186, 4085-4099. 
Blevins, J. S., Beenken, K. E., Elasri, M. O., Hurlburt, B. K., & Smeltzer, M. S., (2002). 
Strain-dependent differences in the regulatory roles of sarA and agr in 
Staphylococcus aureus. Infection and Immunity, 70, 470-480. 
Blevins, J. S., Elasri, M. O., Allmendinger, S. D., Beenken, K. E., Skinner, R. A., 
Thomas, J. R., & Smeltzer, M. S. (2003). Role of sarA in the pathogenesis of 
Staphylococcus aureus musculoskeletal infection. Infection and Immunity, 71, 
516-523. 
Boles, B.R., & Horswill, A.R. (2008). agr-mediated dispersal of Staphylococcus aureus 
biofilms. PLoS Pathogens, 4, e1000053. 
 88 
 
 
Boles, B.R., Thoendel, M., Roth, A.J., & Horswill, A.R. (2010). Identification of genes 
involved in polysaccharide-independent Staphylococcus aureus biofilm 
formation. PLoS One, 5, e10146. 
Boyce, J.M. (1998). Are the epidemiology and microbiology of methicillin-resistant 
Staphylococcus aureus changing? JAMA, 279, 623-624. 
Brandborg, L., & Goldman, I.S. (1990). Bacterial and miscellaneous infections of the 
liver. HepatologyA Textbook of Liver Disease, W.B. Saunders, Philadelphia, 
1086-1098. 
Bubeck-Wardenburg, J., Bae, T., Otto, M., DeLeo, F.R., & Schneewind, O., (2007). 
Poring over pores:-hemolysin and Panton-Valentine leukocidin in Staphylococcus 
aureus pneumonia. Nature Medicine, 13, 1405-1406. 
Burian, M., Wolz, C., & Goerke, C., (2010). Regulatory adaptation of Staphylococcus 
aureus during nasal colonization of humans. PLoS ONE, 5, e10040. 
Burlak, C., Hammer, C.H., Robinson, M.A., Whitney, A.R., McGavin, M.J., Kreiswirth, 
B.N., & Deleo, F.R. (2007). Global analysis of community-associated methicillin-
resistant Staphylococcus aureus exoproteins reveals molecules produced in vitro 
and during infection. Cell Microbiology, 9, 1172-1190. 
Camara, M., Williams, P., & Hardman, A. (2002). Controlling infection by tuning in and 
turning down the volume of bacterial small-talk. The Lancet Infectious Diseases, 
2, 667-676. 
Cassat, J. E., Dunman, P. M., Mcaleese, F., Murphy, E., Projan, S. J., & Smeltzer M. S. 
(2005). Comparative genomics of Staphylococcus aureus musculoskeletal 
isolates. Journal of Bacteriology, 187, 576–592. doi: 10.1128/JB.187.2.576-
592.2005. 
 89 
 
 
Cassat, J., Dunman, P.M., Murphy, E., Projan, S.J., Beenken, K.E., Palm, K.J., Yang, 
S.J., Rice, K.C., Bayles, K.W., & Smeltzer, M.S. (2006). Transcriptional profiling 
of a Staphylococcus aureus clinical isolate and its isogenic agr and sarA mutants 
reveals global differences in comparison to the laboratory strain RN6390. 
Microbiology, 152, 3075-3090. 
Clark, T.J., & Company (1998). Staphylococcus. Retrieved from http://www.tjclarkdirect. 
com/bacterial_diseases/staphylococcus.htm. 
Centers for Disease Control and Prevention. (CDC). (1999). Four pediatric deaths from 
community-acquired methicillin resistant Staphylococcus aureus—Minnesota and 
North Dakota, 1997-1999. Morbidity and Mortality Weekly Report, 48(32):707-
710. 
Centers for Disease Control and Prevention. (CDC). (2003a). Methicillin-resistant 
Staphylococcus aureus infections among competitive sports participants—
Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003. Morbidity 
and Mortality Weekly Report, 2003a; 52(33), 793-795. 
Centers for Disease Control and Prevention. (CDC). (2003b). Outbreaks of community-
associated methicillin-resistant Staphylococcus aureus skin infections—Los 
Angeles County, California, 2002-2003. Morbidity and Mortality Weekly Report, 
2003b, 52(5), 88. 
Charlebois, E. D., Bangsberg, D. R., Moss, N. J., Moore, M. R., Moss, A. R., Chambers, 
H. F., & Perdreau-Remington, F. (2002). Population-based community prevalence 
of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco. 
Clinical Infectious Diseases, 34, 425-433. 
 90 
 
 
Chavakis, T., Hussain, M., Kanse, S.M., Peters, G., Bretzel, R.G., Flock, J.I., Herrmann, 
M., & Preissner, K.T. (2002). Staphylococcus aureus extracellular adherence 
protein serves as anti-inflammatory factor by inhibiting the recruitment of host 
leukocytes. Nature Medicine, 8, 687-693. 
Chen, K. T., Huard, R. C., Della-Latta, P., & Saiman, L. (2006). Prevalence of 
methicillin-sensitive and methicillin-resistant Staphylococcus aureus in pregnant 
women. Obstetrics and Gynecology, 108, 482-487. 
Cheung, A. L., Koomey, J. M., Butler, C. A., Projan, S. J., & Fischetti, V. A. (1992). 
Regulation of exoprotein expression in Staphylococcus aureus by a locus (sar) 
distinct from agr. Proceedings of the National Academy of Sciences of the United 
States of America, 89, 6462-6466. 
Cheung, A.L., & Ying, P. (1994). Regulation of alpha- and beta-hemolysins by the sar 
locus of Staphylococcus aureus. Journal of Bacteriology, 176, 580-585. 
Cheung, A.L., & Zhang, G. (2001). Are the structures of SarA and SarR similar? Trends 
in Microbiology, 9, 570-573. 
Chevalier, C., Boisset, S., Romilly, C., Masquida, B., Fechter, P., Geissmann, T., 
Vandenesch, F., & Romby, P. (2010). Staphylococcus aureus RNAIII binds to 
two distant regions of coa mRNA to arrest translation and promote mRNA 
degradation. PLoS Pathogens, 6, e1000809. doi: 10.1371/journal.ppat.1000809. 
Cramton, S.E., Gerke, C., Schnell, N.F., Nichols, W.W., & Gotz, F. (1999). The 
intercellular adhesion (ica) locus is present in Staphylococcus aureus and is 
required for biofilm formation, Infection & Immunity., 67, 5427-5433. 
Crum, N.F., Lee, R.U., Thornton, S.A., Stine, O.C., Wallace, M.R., Barrozo, C., 
…Russell, K.L. (2006). Fifteen-year study of the changing epidemiology of 
 91 
 
 
methicillin-resistant Staphylococcus aureus. American Journal of Medicine, 119, 
943-51. 
Crisostomo, M. I., Westh, H., Tomasz, A., Chung, M., Oliveira, D.C., & de Lencastre, H. 
(2001). The evolution of methicillin resistance in Staphylococcus aureus: 
similarity of genetic backgrounds in historically early methicillin susceptible and 
resistant isolates and contemporary epidemic clones. Proceedings of the National 
Academy of Sciences of the United States of America, 98, 9865-9870. 
Cucarella, C., Solano, C., Valle, J., Amorena, B., Lasa, I., & Penades, J.R. (2001). Bap, a 
Staphylococcus aureus surface protein involved in biofilm formation. Journal of 
Bacteriology, 183, 2888-2896. 
Corrigan, R.M., Rigby, D.,Handley, P., & Foster, T.J. (2007). The role of Staphylococcus 
aureus surface protein SasG in adherence and biofilm formation Microbiology, 
153, 2435-2446. 
Dassy, B., Hogan, T., Foster, T. J., & Fournier, J. M. (1993). Involvement of the 
accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by 
Staphylococcus aureus. Journal of General Microbiology, 139 (6), 1301-1306. 
DeDent, A. C., McAdow, M., & Schneewind, O. (2007). Distribution of Protein A on the 
Surface of Staphylococcus aureus. Journal of Bacteriology, 189, 4473-4484. 
Degnan, B.A., Fontaine, M.C., Doebereiner, A.H., Lee, J. J., Mastroeni, P., Dougan, G., 
Goodacre, J. A., & Kehoe, M. A. (2000). Characterization of an isogenic mutant 
of Streptococcus pyogenes Manfredo lacking the ability to make streptococcal 
acid glycoprotein. Infection and Immunity, 68, 2441-2448. 
Degnan, B.A., Palmer, J.M., Robson, T., Jones, C.E., Fischer, M., Glanville, M., Mellor, 
G.D., Diamond, A.G., Kehoe, M.A., & Goodacre, J.A. (1998). Inhibition of 
 92 
 
 
human peripheral blood mononuclear cell proliferation by Streptococcus 
pyogenes cell extract is associated with arginine deiminase activity. Infection and 
Immunity, 66, 3050-3058. 
de Haas, C. J., Veldkamp, K.E., Peschel, A., Weerkamp, F., Van Wamel, W.J., Heezius, 
E.C., Poppelier, M.J., Van Kessel, K.P., & van Strijp, JA. (2004). Chemotaxis 
inhibitory protein of Staphylococcus aureus, a bacterial anti-inflammatory agent. 
Journal of Experimental Medicine, 199, 687-695. 
Deora, R., Tseng, T., & Misra, T.K. (1997). Alternative transcription factor sigmaSB of 
Staphylococcus aureus: characterization and role in transcription of the global 
regulatory locus sar. Journal of Bacteriology, 179, 6355-6359. 
Diep, B.A., Gill, S.R., Chang, R.F., Phan, T.H., Chen, J.H., Davidson, M.G., Lin, F., . . . 
Perdreau-Remington, F. (2006). Complete genome sequence of USA300, an 
epidemic clone of community-acquired methicillin resistant Staphylococcus 
aureus. Lancet, 367, 731-739. 
Dirckx, P. & Stoodley, P. (2003). Biofilm formation in 3 steps. Center for Biofilm 
Engineering, Montana State University. Retrieved from https://www2.erc. 
montana.edu/resources/images/multicellularextracellular/biofilm-formation-3-
steps.html. 
Dossett, J.H., Kronvall, G., Williams Jr., R.C., and Quie, P.G. (1969). Antiphagocytic 
effects of staphylococcal protein A. Journal of Immunology, 103, 1405. 
Drapeau, G. R. (1978). Role of a metalloprotease in activation of the precursor of 
staphylococcal protease. Journal of Bacteriology, 136, 607-613. 
 93 
 
 
Dufour, P., Jarraud, S., Vandenesch, F., Greenland, T., Novick, R. P., Bes, M., Etienne, 
J., & Lina G. (2002), High genetic variability of the agr locus in Staphylococcus 
species. Journal of Bacteriology, 184, 1180-1186. 
Dunman, P. M., Murphy, E., Haney, S., Palacios, D., Tucker-Kellogg, G., Wu, S., 
Brown, E. L., . . . Projan, S. J. (2001). Transcription profiling-based identification 
of Staphylococcus aureus genes regulated by the agr and/or sarA loci. Journal of 
Bacteriology, 183, 7341-7353. 
Durr, M.C., Kristian, S.A., Otto, M., Matteoli, G., Margolis, P.S., Trias, J., van Kessel, 
K.P., . . . Peschel, A. (2006). Neutrophil chemotaxis by pathogen-associated 
molecular patterns–formylated peptides are crucial but not the sole neutrophil 
attractants produced by Staphylococcus aureus. Cellular Microbiology, 8, 207-
217. 
Enright, M.C., Day, N.P., Davies, C.E., Peacock, S.J., & Spratt, B.G. (2000). Multilocus 
sequence typing for characterization of methicillin-resistant and methicillin-
susceptible clones of Staphylococcus aureus. Journal of Clinical Microbiology, 
38, 1008-1015. 
Enright, M. C., Robinson, D., Randle, G., Feil, E. J., Grundmann, H. & Spratt, B. G. 
(2002). The evolutionary history of methicillin-resistant Staphylococcus aureus 
(MRSA). Proceedings of the National Academy of Sciences of the United States 
of America, 99, 7687-7692. 
Fey, P.D., & Olson, M.E., (2010). Current concepts in biofilm formation of 
Staphylococcus epidermidis. Future Microbiology, 5, 917-933. 
Flock, J.I., Froman, G., Jonsson, K., Guss, B., Signas, C., Nilsson, B., Raucci, G., Hook, 
M., Wadstrom, T., & Lindberg, M. (1987). Cloning and expression of the gene for 
 94 
 
 
a fibronectin-binding protein from Staphylococcus aureus. Embo Journal, 6, 
2351-2357. 
Foster, T.J. (2005). Immune evasion by staphylococci. Nature Reviews Microbiology, 3, 
948-958. 
Foster T.J., & McDevitt D. (1994). Surface-associated proteins of Staphylococcus 
aureus: their possible roles in virulence. FEMS Microbiol Letter, 118, 199-205. 
Francis, J.S., Doherty, M.C., Lopatin, U., Johnston, C.P., Sinha, G., Ross, T., Cai, M., . . . 
Bartlett, J.G., (2005). Severe community-onset pneumonia in healthy adults 
caused by methicillin-resistant Staphylococcus aureus carrying the Panton-
Valentine leukocidin genes. Clinical Infectious Diseases, 40(1), 100-107. 
Fridkin, S.K., Hageman, J.C., Morrison, M., Sanza, L.T., Como-Sabetti, K., Jernigan, 
J.A., Harriman, K., . . . Farley, M.M., for the Active Bacterial Core Surveillance 
Program of the Emerging Infections Program Network, (2005). Methicillin-
resistant Staphylococcus aureus disease in three communities. New England 
Journal of Medicine, 352(14), 1436-1444. 
Garcia-Lara, J., Masalha, M., & Foster, S.J. (2005). Staphylococcus aureus: the search 
for novel targets, Drug Discovery Today, 10(9), 643-651. 
Geisinger, E., Adhikari, R.P., Jin, R., Ross, H.F., & Novick, R.P. (2006). Inhibition of rot 
translation by RNAIII, a key feature of agr function. Molecular Microbiology, 
61(4), 1038-48.  
Gemmell, C., Tree, R., Patel, A., O’Reilly, M., & Foster, T. J. (1991). Susceptibility to 
opsonophagocytosis of protein A, α-haemolysin and β-toxin deficient mutants of 
Staphylococcus aureus isolated by allele-replacement. Zentralbl. Bakteriol. 21 
(Suppl.), 273-277. 
 95 
 
 
Gillaspy, A. F., Hickmon, S. G., Skinner, R. A., Thomas, J. R., Nelson, C. L., & 
Smeltzer, M. S. (1995). Role of the accessory gene regulator (agr) in pathogenesis 
of staphylococcal osteomyelitis. Infection and Immunity, 63, 3373–3380. 
Gillaspy, A.F., Lee, C.Y., Sau, S., Cheung, A.L., & Smeltzer, M.S. (1998). Factors 
affecting the collagen binding capacity of Staphylococcus aureus. Infection and 
Immunity, 66, 3170–3178. 
Graffunder, E.M., & Venezia, R.A. (2002). Risk factors associated with nosocomial 
methicillin-resistant Staphylococcus aureus (MRSA) infection including previous 
use of antimicrobials. Journal of Antimicrobial Chemotherapy, 49, 999-1005. 
Graham, J.E., & Wilkinson, B.J., (1992). Staphylococcus aureus osmoregulation: roles of 
choline, glycine betaine, proline and taurine. Journal of Bacteriology, 174, 2711-
16. 
Gray, G.S., & Kehoe, M. (1984). Primary sequence of the alpha-toxin gene from 
Staphylococcus aureus wood 46. Infection and Immunity, 46(2), 615–618. 
Gregory, S.H., Sagnimeni, A.J., & Wing, E.J. (1996). Bacteria in the bloodstream are 
trapped in the liver and killed by immigrating neutrophils. Journal of 
Immunology, 157, 2514-2520. 
Gresham, H. D., Lowrance, J.H., Caver, T.E., Wilson, B.S., Cheung, A.L., & Lindberg, 
F.P., (2000). Survival of Staphylococcus aureus inside neutrophils contributes to 
infection. Journal of Immunology, 164, 3713-3722. 
Griffin, B.R., & Hamilton, L. (2010). Progression of a Recurrent Community-Acquired 
Methicillin-Resistant Staphylococcus aureus (MRSA) Infection. LabMedicine, 
41, 329-333. 
 96 
 
 
Gouwy, M., Struyf, S., Catusse, J., Proost, P., & Van Damme, J., (2004). Synergy 
between proinflammatory ligands of G protein coupled receptors in neutrophil 
activation and migration. Journal of Leukocyte Biology, 76, 185-194. 
Haas, P.J., de Haas, C.J., Kleibeuker, W., Poppelier, M.J., van Kessel, K.P.M., Kruijtzer, 
J.A., Liskamp, R.M., & van Strijp, J.A. (2004). N-terminal residues of the 
chemotaxis inhibitory protein of Staphylococcus aureus are essential for blocking 
formylated peptide receptor but not C5a receptor. Journal of Immunology, 173, 
5704-5711. 
Haley, R.W., Cushion, N.B., Tenover, F.C., Bannerman, T.L., Dryer, D., Ross, J., 
Sánchez, P.J., & Siegel, J.D. (1995). Eradication of endemic methicillin-resistant 
Staphylococcus aureus infections from a neonatal intensive care unit. Journal of 
Infectious Diseases, 171, 614-624. 
Hartman, B. J., & Tomasz, A. (1984). Low-affinity penicillin-binding protein associated 
with beta-lactam resistance in Staphylococcus aureus. Journal of Bacteriology, 
158, 513-516. 
Hedetniemi K., & Liao, M.K. (2010). Staphylococcus aureus. American Society for 
Microbiology Microbe Library. Retrieved from http://www.microbelibrary.org/ 
library/2-associated-figure-resource/1660-staphylococcus-aureus-enlarged-view. 
Herold, B.C., Immergluck, L.C., Maranan, M.C., Lauderdale, D.S., Gaskin, R.E., Boyle-
Vavra, S., Leitch, C.D., & Daum, R.S. (1998). Community-acquired methicillin-
resistant Staphylococcus aureus in children with no identified predisposing risk. 
JAMA, 279, 593-598. 
Highlander, S.K., Hulten, K.G., Qin, X., Jiang, H., Yerrapragada, S., Mason, E.O., 
Shang, Y., . . . Weinstock, G.M. (2007). Subtle genetic differences enhance 
 97 
 
 
virulence of methicillin resistant and susceptible Staphylococcus aureus. BMC 
Microbiology, 7, 99. 
Hildebrand, A., Pohl, M., & Bhakdi, S., (1991). Staphylococcus aureus alpha-toxin. Dual 
mechanism of binding to target cells. Journal of Biological Chemistry, 266, 
17195-17200. 
Ito, T., Katayama, Y., Asada, K., Mori, N., Tsutsumimoto, K., Tiensasitorn, C., & 
Hiramatsu, K., (2001). Structural comparison of three types of staphylococcal 
cassette chromosome mec integrated in the chromosome in methicillin-resistant 
Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 45, 1323-1336. 
Izano, E.A., Amarante, M.A., Kher, W.B., & Kaplan, J.B. (2008). Differential roles of 
poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in 
Staphylococcus aureus and Staphylococcus epidermidis biofilms. Applied 
Environmental Microbiology, 74, 470-476. 
Janzon, L., & Arvidson, S. (1990). The role of the delta-lysin gene (hld) in the regulation 
of virulence genes by the accessory gene regulatory (agr) in Staphylococcus 
aureus. EMBO Journal, 9, 1391-1399. 
Jarraud, S., Lyon, G.J., Figueiredo, A.M., Lina, G., Vandenesch, F., Etienne, J., Muir, 
T.W., & Novick, R.P. (2000). Exfoliatin-producing strains define a fourth agr 
specificity group in Staphylococcus aureus. Journal of Bacteriology, 182, 6517-
6522. 
Jayasinghe L., & Bayley H. (2005). The leukocidin pore: evidence for an octamer with 
four LukF subunits and four LukS subunits alternating around a central axis. 
Protein Science, 14, 2550-2561. doi: 10.1110/ps.051648505. 
 98 
 
 
Jevons, M.P., Coe, A.W., & Parker, M.T., (1963). Methicillin resistance in staphylococci. 
Lancet, 1, 904-907. 
Jevons, M. P., (1961). “Celbenin” resistant staphylococci. BMJ, 1, 124–125. 
Ji, G., Beavis, R., & Novick, R. P. (1997). Bacterial interference caused by autoinducing 
peptide variants. Science, 276, 2027–2030.  
Jin, T., Bokarewa, M., Foster, T., Mitchell, J., Higgins, J., & Tarkowski, A. (2004). 
Staphylococcus aureus resists human defensins by production of staphylokinase, a 
novel bacterial evasion mechanism. Journal of Immunology, 172, 1169-1176. 
Jonsson, P., Lindberg, M., Harroldson, I., & Wadstrom, T. (1985). Virulence of 
Staphylococcus aureus in a mouse mastitis model: studies of alpha hemolysin, 
coagulase, and protein A as possible virulence determinants with protoplast fusion 
and gene cloning. Infection and Immunology, 49, 765-769.  
Jonsson, K., Signäs, C., Muller, H. P., & Lindberg, M. (1991). Two different genes 
encode fibronectin binding proteins in Staphylococcus aureus. The complete 
nucleotide sequence and characterization of the second gene. European Journal of 
Biochemistry, 202, 1041-1048. 
Josefsson, E., Hartford, O., O’Brien, L., Patti, J. M., & Foster, T. (2001). Protection 
against experimental Staphylococcus aureus arthritis by vaccination with 
clumping factor A, a novel virulence determinant. Journal of Infectious Diseases. 
184, 1572-1580. 
Kaida, S., Miyata, T., Yoshizawa, Y., Igarashi, H., & Iwanaga, S. (1989). Nucleotide and 
deduced amino acid sequences of staphylocoagulase gene from Staphylococcus 
aureus strain 213. Nucleic Acids Research, 17, 8871. 
 99 
 
 
Kaplan, S.L., Hulten, K.G., Gonzalez, B.E., Hammerman, W.A., Lamberth, L., 
Versalovic, J., & Mason Jr., E.O. (2005). Three year surveillance of community-
acquired Staphylococcus aureus infections in children. Clinical Infectious 
Diseases, 40(12), 1785-1791. 
Karlsson A., & Arvidson S (2002). Variation in extracellular protease production among 
clinical isolates of Staphylococcus aureus due to different levels of expression of 
the protease repressor sarA. Infection and Immunity, 70, 4239-4246. 
Karchmer, A. W. (2000). Nosocomial bloodstream infections: organisms, risk factors, 
and implications. Clinical Infectious Diseases, 31(Suppl. 4), S139-S143. 
Katayama, Y., Ito, T., & Hiramatsu, K. (2000). A new class of genetic element, 
staphylococcus cassette chromosome mec, encodes methicillin resistance in 
Staphylococcus aureus. Antimicrobial Agents and Chemotherapy, 44(6), 1549-
1555. 
Kennedy, A.D., Otto, M., Braughton, K.R., Whitney, A.R., Chen, L., Mathema, B., 
Mediavilla, J.R., . . . DeLeo, F.R. (2008). Epidemic community-associated 
methicillin-resistant Staphylococcus aureus: recent clonal expansion and 
diversification. Proceedings of the National Academy of Sciences of the United 
States of America, 105, 1327-1332. 
Klevens, R., Morrison, M.A., Nadle, J., Petit, S., Gershman, K., Ray, S., Harrison, L.H., . 
. . Fridkin, S.K.; Active Bacterial Core surveillance (ABCs) MRSA Investigators. 
et al. (2007). Invasive Methicillin-Resistant Staphylococcus aureus Infections in 
the United States. JAMA, 298(15), 1763-1771. doi:10.1001/jama.298.15.1763. 
 100 
 
 
Klevens, R.M., Edwards, J.R., Gaynes, R.P., & NNIS System (2008). The impact of 
antimicrobial-resistant, health care-associated infections on mortality in the 
United States. Clinical Infectious Diseases, 47, 927-930. 
Klevens, R.M., Edwards, J.R., Tenover, F.C., McDonald, L.C., Horan, T., Gaynes, R. 
(2006). Changes in the epidemiology of methicillin-resistant Staphylococcus 
aureus in intensive care units in U.S. hospitals, 1992-2003. Clinical Infectious 
Diseases, 42(3), 389-391. 
Kreisel, K.M., Stine, O.C., Johnson, J.K., Perencevich, E.N., Shardell, M.D., Lesse, A.J., 
Gordin, F.M., . . . Roghmann, M.C. (2011). USA300 methicillin-resistant 
Staphylococcus aureus bacteremia and the risk of severe sepsis: is USA300 
methicillin-resistant Staphylococcus aureus associated with more severe 
infections? Diagnostic Microbiology and Infectious Disease, 70, 285-290. 
Kubica, M., Guzik, K., Koziel, J., Zarebski, M., Richter, W., Gajkowska, B., Golda, A., . 
. . Potempa, J. (2008). A Potential New Pathway for Staphylococcus aureus 
Dissemination: The Silent Survival of S. aureus Phagocytosed by Human 
Monocyte-Derived Macrophages. PLoS ONE, 3(1), e1409. 
doi:10.1371/journal.pone.0001409. 
Kuehnert, M.J., Hill, H.A., Kupronis, B.A., Tokars, J.I., Solomon, S.L., & Jernigan, D.B. 
(2005). Methicillin‐resistant–Staphylococcus aureus hospitalizations United 
States. Emerging Infectious Disease, 11, 868-872. 
Kuroda, M., Ohta, T., Uchiyama, I., Baba, T., Yuzawa, H., Yobayashi, I., . . . Hiramatsu, 
K. (2001). Whole genome sequencing of meticillin-resistant Staphylococcus 
aureus. Lancet, 357, 1225-1240. 
 101 
 
 
Langley, R., Wines, B., Willoughby, N., Basu, I., Proft, T., & Fraser, J.D., (2005). The 
staphylococcal superantigen-like protein 7 binds IgA and complement C5 and 
inhibits IgA-Fc alpha RI binding and serum killing of bacteria. Journal of 
Immunology, 174, 2926-2933. 
Lauderdale, K.J., Boles, B.R., Cheung, A.L., & Horswill, A.R. (2009). Interconnections 
between Sigma B, agr, and proteolytic activity in Staphylococcus aureus biofilm 
maturation. Infection and Immunity, 77, 1623-1635. 
Lauderdale, K.J., Boles, B.R., Morcuende, J., & Horswill, A.R. (2010). Biofilm dispersal 
of community-associated methicillin-resistant Staphylococcus aureus on 
orthopaedic implant material. Journal of Orthopedic Research, 28, 55-61. 
Lee, J.C., Xu S., Albus, A., & Livolsi, P.J. (1994). Genetic analysis of type 5 capsular 
polysaccharide expression by Staphylococcus aureus. Journal of Bacteriology, 
176, 4883-4889. 
Lee, L.Y., Hook, M., Haviland, D., Wetsel, R.A., Yonter, E.O., Syribeys, P., Vernachio, 
J., & Brown, E.L. (2004a). Inhibition of complement activation by a secreted 
Staphylococcus aureus protein. Journal of Infectious Diseases, 190, 571-579. 
Lee, L.Y., Liang, X., Hook, M., & Brown, E.L. (2004b). Identification and 
characterization of the C3 binding domain of the Staphylococcus aureus 
extracellular fibrinogen-binding protein (Efb). Journal of Biological Chemistry, 
279, 50710-50716. 
Li, M., Diep, B.A., Villaruz, A.E., Braughton, K.R., Jiang, X., DeLeo, F.R., Chambers, 
H.F., Lu, Y., & Otto, M. (2009). Evolution of virulence in epidemic community-
associated methicillin-resistant Staphylococcus aureus. Proceedings of the 
National Academy of Sciences of the United States of America, 106, 5883-5888. 
 102 
 
 
Lin, M.Y., Weinstein, R.A., & Hota, B., (2008). Delay of active antimicrobial therapy 
and mortality among patients with bacteremia: impact of severe neutropenia. 
Antimicrobial Agents and Chemotherapy, 52, 3188-3194. 
Lina, G., Jarraud, S., Ji, G., Greenland, T., Pedraza, A., Etienne, J., Novick, R.P., & 
Vandenesch, F. (1998). Transmembrane topology and histidine protein kinase 
activity of AgrC, the agr signal receptor in Staphylococcus aureus. Molecular 
Microbiology, 28, 655-662. 
Lindberg, M., Jonsson, K., Muller, H., Jonsson, H., Signas, C., Hook, M., Raja, R., 
Raucci, G., & Anantharamaiah, G.M. (1990), Fibronectin-binding proteins in 
Staphylococcus aureus. In Novick,R.P., editor. Molecular Biology of the 
Staphylococci, 327-356. 
Lindsay, J.A., & Foster, S.J. (1999). Interactive regulatory pathways control virulence 
determinant production and stability in response to environmental conditions in 
Staphylococcus aureus. Molecular and General Genetics, 262, 323-331. 
Liu, C., Bayer, A., Cosgrove, S.E., Daum, R.S., Fridkin, S.K., Gorwitz, R.J., Kaplan, . . . 
Chambers, H.F. (2011). Clinical practice guidelines by the Infectious Diseases 
Society of America for the treatment of methicillin-resistant Staphylococcus 
aureus infections in adults and children: executive summary. Clinical Infectious 
Diseases, 52, 285-92. 
Liu, G.Y., Essex, A., Buchanan, J.T., Datta, V., Hoffman, H.M., Bastian, J.F., Fierer, J., 
& Nizet, V. (2005). Staphylococcus aureus golden pigment impairs neutrophil 
killing and promotes virulence through its antioxidant activity. Journal of 
Experimental Medicine, 202(2), 209-215.  
 103 
 
 
Lodise Jr., T.P., McKinnon, P.S., & Rybak, M., (2003). Prediction model to identify 
patients with Staphylococcus aureus bacteremia at risk for methicillin resistance. 
Infection Control and Hospital Epidemiology, 24, 655-61. 
Lofdahl, S., Guss, B., Uhlen, M., Philipson, L., & Lindberg, M. (1983). Gene for 
Staphylococcal protein A. Proceedings of the National Academy of Sciences of 
the United States of America, 80, 697-701. 
Lowy, F. D. (1998). Staphylococcus aureus infections. The New England Journal of 
Medicine, 339, 520-532. 
Lowy F.D. (2000). Is Staphylococcus aureus an intracellular pathogen. Trends in 
Microbiology, 8, 341-343. 
Luong, T., Sau, S., Gomez, M., Lee, J.C., & Lee, C.Y. (2002). Regulation of 
Staphylococcus aureus capsular polysaccharide expression by agr and sarA. 
Infection and Immunity, 13, 444-450. 
Luong, T. T., & Lee, C.Y. (2002). Overproduction of type 8 capsular polysaccharide 
augments Staphylococcus aureus virulence. Infection and Immunity, 70, 3389-
3395. 
Ma, X.X., Ito, T., Tiensasitorn, C., Jamklang, M., Chongtrakool, P., Boyle-Vavra, S., 
Daum, R.S., & Hiramatsu, K. (2002). Novel type of staphylococcal cassette 
chromosome mec identified in community-acquired methicillin-resistant 
Staphylococcus aureus strains. Antimicrobial Agents and Chemotherapy, 46(4), 
1147-1152. 
Mackaness, G.B. (1962). Cellular resistance to infection. Journal of Experimental 
Medicine, 116, 381. 
 104 
 
 
Mallonee, D.H., Glatz, B.A., & Pattee, P.A. (1982). Chromosomal mapping of a gene 
affecting enterotoxin A production in Staphylococcus aureus. Applied and 
Environmental Microbiology, 43(2), 397-402. 
Manna, A. C., Bayer, M.G., & Cheung, A.L. (1998). Transcriptional analysis of different 
promoters in the sar locus in Staphylococcus aureus. Journal of Bacteriology, 
180, 3828-3836. 
Mann, E.E., Rice, K.C., Boles, B.R., Endres, J.L., Ranjit, D., Chandramohan, L., Tsang, 
L.H., Smeltzer, M.S., Horswill, A.R., & Bayles, K.W. (2009). Modulation of 
eDNA release and degradation affects Staphylococcus aureus biofilm maturation. 
PLoS ONE, 4(6), e5822. 
Martin, G.S., Mannino, D.M., Eaton, S., & Moss, M., (2003). The epidemiology of sepsis 
in the United States from 1979 to 2000. New England Journal of Medicine, 348, 
1546-1554. 
McAdow, M., Kim, H. K., Dedenta, A. C., Hendrickx, A. P. A., Schneewind, O., 
Missiakas, D. M. (2011). Preventing Staphylococcus aureus sepsis through the 
inhibition of its agglutination in blood. PLoS Pathogens, 7, e1002307. 
McCartney, C., & Arbuthnott, J. P. (1978). Mode of action of membrane damaging toxins 
produced by staphylococci, p 89-127 In Jebzewicz, J., and Wadstrom, T., (ed.), 
Bacterial Toxins and Cell Membranes, London, UK: Academic Press.  
McDevitt, D., Francois, P., Vaudaux, P., & Foster, T. J. (1994). Molecular 
characterization of the clumping factor (fibrinogen receptor) of Staphylococcus 
aureus. Molecular Microbiology, 11, 237-248. 
McDougal, L.K., Steward, C.D., Killgore, G.E., Chaitram, J.M., McAllister, S.K., & 
Tenover, F.C. (2003). Pulsed-field gel electrophoresis typing of oxacillin-resistant 
 105 
 
 
Staphylococcus aureus isolates from the United States: establishing a national 
database. Journal of Clinical Microbiology, 41, 5113-5120. doi: 
10.1128/JCM.41.11.5113-5120.2003. 
McDougal, L.K., Wenming, Z., Patel, J.B., & Tenover, F.C. (2004). Characterization of 
two new community-associated oxacillin resistant Staphylococcus aureus pulsed-
field types consisting of US isolates that carry SCCmec IV and Panton-Valentine 
leukocidin genes. Abstr. 104th General Meeting American Society of 
Microbiology, New Orleans, LA. 
McDowell, P., Affas, Z., Reynolds, C., Holden, M.T.G., Wood, S.J., Saint, S., Cockayne, 
A., Hill, P.J., Dodd, C.E.R., Bycroft, B.W., Chan, W.C., & Williams, P. (2001). 
Structure, activity and evolution of the group I thiolactone peptide quorum-
sensing system of Staphylococcus aureus. Molecular Microbiology, 41, 503-512. 
McGavin, M.J, Zahradka, C., Rice, K., & Scott, J.E. (1997). Modification of the 
Staphylococcus aureus fibronectin binding phenotype by V8 protease. Infection 
and Immunity, 65, 2621-2628. 
McGavin, M.J., Arsic, B., & Nickerson, N.N. (2012). Evolutionary blueprint for host- 
and niche-adaptation in Staphylococcus aureus clonal complex CC30. Frontiers 
in Cellular and Infection Microbiology, 2, 48. doi: 10.3389/fcimb.2012.00048. 
Merino, N., Toledo-Arana, A., Vergara-Irigaray, M., Valle, J., Solano, C., E., Calvo, E., 
Lopez, J.A., Foster, T.J., Penades, J.R., & Lasa, I. (2009). Protein A-mediated 
multicellular behavior in Staphylococcus aureus, Journal of Bacteriology, 191, 
832-843. 
Merino, N., Toledo-Arana, A., Vergara-Irigaray, M., Valle, J., Solano, C., Calvo, E., 
Lopez, J.A., Foster, T.J., Penades, J.R., & Lasa, I., (2009). Protein A-mediated 
 106 
 
 
multicellular behavior in Staphylococcus aureus. Journal of Bacteriology, 191, 
832-843. 
Mertz, D., Frei, R., Jaussi, B., Tietz, A., Stebler, C., Flückiger, U., & Widmer, .AF. 
(2007). Throat swabs are necessary to reliably detect carriers of Staphylococcus 
aureus. Clinical Infectious Diseases, 45(4), 475-477. 
Mertz, D., Frei, R., Periat, N., Zimmerli, M., Battegay, M., Flückiger, U., & Widmer, 
A.F. (2009). Exclusive Staphylococcus aureus throat carriage at-risk populations. 
Archives of Internal Medicine, 169(2), 172-178. 
Menestrina, G., Dalla Serra, M., Comai, M., Coraiola, M., Viero, G., Werner, S., Colin, 
D.A., Monteil, H., & Prévost, G. (2003). Ion channels and bacterial infection: the 
case of β-barrel pore-forming protein toxins of Staphylococcus aureus. FEBS 
Letters, 552, 54-60. 
Menzies, B.E., & Kourteva, I. (1998). Internalization of Staphylococcus aureus by 
endothelial cells induces apoptosis. Infection and Immunity, 66, 5994-5998. 
Miller, L. G., Perdreau-Remington, F., Rieg, G., Mehdi, S., Perlroth, J., Bayer, A.S., 
Tang, A.W., Phung, T.O., & Spellberg, B. (2005). Necrotizing fasciitis caused by 
community-associated methicillin-resistant Staphylococcus aureus in Los 
Angeles. New England Journal of Medicine, 352, 1445–1453. 
Mims, C. A. (1987). The Pathogenesis of infectious diseases (3
rd
 ed.). London Academic 
Press, 105. 
Montgomery, C.P., Boyle-Vavra, S., Adem, P.V., Lee, J.C., Husain, A.N., Clasen, J., & 
Daum, R.S., (2008). Comparison of virulence in community-associated 
methicillin-resistant Staphylococcus aureus pulsotypes USA300 and USA400 in a 
rat model of pneumonia. Journal of Infectious Diseases, 198, 561-570. 
 107 
 
 
Montoya, M., & Gouaux, E. (2003). β-barrel membrane protein folding and structure 
viewed through the lens of α-hemolysin. Biochimica et Biophysica Acta, 1609, 
19-27. 
Moran, G. (2010). Methicillin Resistant Staphylococcus aureus. Centers for Disease 
Control and Prevention. Retrieved from http://www.cdc.gov/mrsa/ 
mrsa_initiative/skin_infection/mrsa_photo_007.html. 
Moran, G.J., Krishnadasan, A., Gorwitz, R.J., Gregory, E., Fosheim, Linda, K., 
McDougal, M.S., Carey, R.B., & Talan, D. A., (2006). Methicillin-resistant S. 
aureus infections among patients in the emergency department. New England 
Journal of Medicine, 355(7), 666-674. 
Morfeldt, E., Taylor, D., von Gabain, A., & Arvidson, S. (1995). Activation of alpha-
toxin translation in Staphylococcus aureus by the trans-encoded antisense RNA, 
RNAIII. EMBO Journal, 14, 4569-4577. 
Nagarajan, V., & Elasri, M.O. (2007). Structure and function predictions of the Msa 
protein in Staphylococcus aureus. BMC Bioinformatics, 8(Suppl 7), S5. 
Naimi, T.S., LeDell, K.H., Como-Sabetti, K., Borchardt, S.M., Boxrud, D.J., Etienne, J., 
Johnson, S.K., Vandenesch, F., Fridkin, S., O'Boyle, C., Danila, R.N., & Lynfield, 
R. (2003). Comparison of community- and health care-associated methicillin-
resistant Staphylococcus aureus infection. JAMA, 290, 2976-84. 
Nair, S.P., Bischoff, M., Senn, M.M., & Berger-Bachi, B. (2003). The sigma B regulon 
influences internalization of Staphylococcus aureus by osteoblasts. Infection and 
Immunity, 71, 4167-4170. 
National Committee for Clinical Laboratory Standards. (1997). Methods for dilution 
antimicrobial susceptibility tests for bacteria that grow aerobically. Approved 
 108 
 
 
standard M7-A4. (National Committee for Clinical Laboratory Standards, 
Villanova, PA). 
Nguyen, D.M., Bancroft, E., Mascola, L., Guevara, R., & Yasuda, L., (2007). Risk 
factors for neonatal methicillin-resistant Staphylococcus aureus infection in a 
well-infant nursery. Infection Control and Hospital Epidemiology, 28, 406-411. 
Nilsson, I. M., Lee, J. C., Bremell, T., Ryden, C., & Tarkowski, A. (1997). The role of 
staphylococcal polysaccharide microcapsule expression in septicemia and septic 
arthritis. Infection and Immunity, 65, 4216-4221. 
Novick, R.P., Ross, H.F., Projan, S.J., Kornblum, J., Kreiswirth, B., & Moghazeh, S. 
(1993). Synthesis of staphylococcal virulence factors is controlled by a regulatory 
RNA molecule. EMBO Journal, 12(10), 3967-3975. 
Novick, R.P., & Jiang, D. (2003). The staphylococcal saeRS system coordinates 
environmental signals with agr quorum sensing. Microbiology, 149, 2709-2717. 
O'Brien, L., Kerrigan, S.W., Kaw, G., Hogan, M., Penadés, J., Litt, D., Fitzgerald, D.J., 
Foster, T.J., & Cox, D. (2002). Multiple mechanisms for the activation of human 
platelet aggregation by Staphylococcus aureus: roles for the clumping factors 
ClfA and ClfB, the serine aspartate repeat protein SdrE and protein A. Molecular 
Microbiology, 44, 1033-1044. 
O'Neill, E., Pozzi, C., Houston, P., Smyth, D., Humphreys, H., Robinson, D.A., & 
O’Gara, J.P. (2007). Association between methicillin susceptibility and biofilm 
regulation in Staphylococcus aureus isolates from device-related infections. 
Journal of Clinical Microbiology, 45, 1379-1388. 
O'Neill, E., Pozzi, C., Houston, P., Humphreys, H., Robinson, D.A., Loughman, A., 
Foster, T.J., & O'Gara J.P. (2008). A novel Staphylococcus aureus biofilm 
 109 
 
 
phenotype mediated by the fibronectin-binding proteins, FnBPA and FnBPB. 
Journal of Bacteriology, 190, 3835-3850. 
O’Reilly, M., Azavedo, J. C. S., Kennedy, S., & Foster, T.J. (1986). Inactivation of the 
alpha-haemolysin gene of Staphylococcus aureus 8325-4 by site-directed 
mutagenesis and studies on the expression of its haemolysins. Microbial 
Pathogenesis, 1, 125-138. 
O’Seaghdha, M., van Schooten, C.J., Kerrigan, S.W., Emsley, J., Silverman, G.J., Cox, 
D., Lenting, P.J., & Foster, T.J. (2006). Staphylococcus aureus protein A binding 
to von Willebrand factor A1 domain is mediated by conserved IgG binding 
regions. FEBS Journal, 273, 4831-4841. 
Ofek, I., & Sharon, N. (1988). Lectinophagocytosis: a molecular mechanism of 
recognition between cell surface sugars and lectins in the phagocytosis of 
bacteria. Infection and Immunity, 56(3), 539-547. 
Ogston, A. (1880). Über Abscesse. Arch. Klin. Chir. 25, 588-600. 
Ogston, A. (1881). Report upon micro-organisms in surgical diseases. British Medical 
Journal, 1, 369-375. 
Okuma, K., Iwakawa, K., Turnidge, J.D., Grubb, W.B., Bell, J.M., O’Brien, F.G., 
Coombs, G.W., Pearman, J.W., Tenover, F.C., Kapi, M., Tiensasitorn, C., Ito, T., 
& Hiramatsu, K. (2002). Dissemination of new methicillin-resistant 
Staphylococcus aureus clones in the community. Journal of Clinical 
Microbiology, 40, 4289-94. doi: 10.1128/JCM.40.11.4289-4294.2002. 
Oscarsson, J., Tegmark-Wisell, K., & Arvidson, S., (2006). Coordinated and differential 
control of aureolysin (aur) and serine protease (sspA) transcription in 
 110 
 
 
Staphylococcus aureus by sarA, rot and agr (RNAIII). Internal Journal of 
Medical Microbiology, 296, 365-380. 
Otto, M., Echner, H., Voelter, W., & Gotz, F. (2001). Pheromone cross-inhibition 
between Staphylococcus aureus and Staphylococcus epidermidis. Infection and 
Immunity, 69, 1957-1960. 
Palazzolo-Balance, A.M., Reniere, M.L., Braughton, K.R., Sturdevant, D.E., Otto, M., 
Kreiswirth, B.N., Skaar, E.P., & DeLeo, F.R. (2008). Neutrophil microbicides 
induce a pathogen survival response in community-associated methicillin-
resistant Staphylococcus aureus. Journal of Immunology, 180, 500-509. 
Palmqvist, N., Foster, T., Tarkowski, A. & Josefsson, E. (2002). Protein A is a virulence 
factor in Staphylococcus aureus arthritis and septic death. Microbial 
Pathogenesis, 33, 239-249. 
Palmqvist, N., Patti, J. M., Tarkowski, A., & Josefsson, E. (2004). Expression of 
staphylococcal clumping factor A impedes macrophage phagocytosis. Microbes 
and Infection, 6, 188-195. 
Pan, E.S., Diep, B.A., Charlebois, E.D., Auerswald, C., Carleton, H.A., Sensabaugh, 
G.F., & Perdreau-Remington, F. (2005). Population dynamics of nasal strains of 
methicillin-resistant Staphylococcus aureus—and their relation to community-
associated disease activity. Journal of Infectious Diseases, 192, 811-818. 
Pang, Y.Y., Schwartz, J., Thoendel, M., Ackermann, L.W., Horswill, A.R., & Nauseef, 
W.M. (2010). agr-Dependent Interactions of Staphylococcus aureus USA300 
with Human Polymorphonuclear Neutrophils. Journal of Innate Immunology, 2, 
546-559. 
 111 
 
 
Panlilio, A.L., Culver, D.H., Gaynes, R.P., Banerjee, S., Henderson, T.S., Tolson, J.S., & 
Martone, W.J., (1992). Methicillin-resistant Staphylococcus aureus in U.S. 
hospitals, 1975-1991. Infection Control and Hospital Epidemiology, 13, 582-586. 
Patel, A. H., Nowlan, P., Weavers, E. D. & Foster, T. (1987). Virulence of protein A-
deficient and α-toxin-deficient mutants of Staphylococcus aureus isolated by 
allele replacement. Infection and Immunity, 55, 3103-3110. 
Patti, J. M., Jonsson, H., Guss, B., Switalski, L.M., Wiberg, K., Lindberg, M., & Hook, 
M. (1992). Molecular characterization and expression of a gene encoding a 
Staphylococcus aureus collagen adhesin. Journal of Biological Chemistry, 267, 
4766-4772. 
Peacock, S.J., de Silva, I., & Lowy, F.D. (2001). What determines nasal carriage of 
Staphylococcus aureus? Trends in Microbiology, 9, 605-610. 
Peacock, S.J., Moore, C.E., Justice, A., Kantzanou, M., Story, L., Mackie, K., O'Neill, 
G., & Day, N.P. (2002). Virulent combinations of adhesin and toxin genes in 
natural populations of Staphylococcus aureus. Infection and Immunity, 70, 4987-
4996. 
Peng, H.L., Novick, R.P., Kreiswirth, B., Kornblum, J., & Schlievert, P. (1988). Cloning, 
characterization, and sequencing of an accessory gene regulator (agr) in 
Staphylococcus aureus. Journal of Bacteriology, 170, 4365-4372. 
Perry, A, Keisari, Y., & Ofek, I. (1985). Liver cell and macrophage surface lectins as 
determinants of recognition in blood clearance and cellular attachment of bacteria. 
FEMS Microbiology Letters, 27, 345-350. 
 112 
 
 
Perry, A., & Ofek. (1984). Inhibition of blood clearance and hepatic tissue binding of 
Escherichia coli by liver lectin-specific sugars and glycoproteins. Infection and 
Immunity, 43(1), 257-262. 
Peterson, P.K., Verhoef, J., Sabath, L.D., & Quie, P.G. (1977). Effect of protein A on 
staphylococcal opsonization. Infection and Immunity, 15, 760-764. 
Projan S. J., Kornblum J., Kreiswirth B., Moghazeh S. L., Eisner W., & Novick R. P. 
(1989). Nucleotide sequence: the β-hemolysin gene of Staphylococcus aureus. 
Nucleic Acids Research, 17, 3305. 
Que, Y.A., Haefliger, J.A., Francioli, P., & Moreillon, P., (2000). Expression of 
Staphylococcus aureus clumping factor A in Lactococcus lactis subsp. cremoris 
using a new shuttle vector. Infection and Immunity, 68, 3516-3523. 
Rechtin, T. M., Gillaspy, A.F., Schumacher, M.A., Brennan, R.G., Smeltzer, M.S. & 
Hurlburt, B.K. (1999). Characterization of the SarA virulence gene regulator of 
Staphylococcus aureus. Molecular Microbiology, 33, 307-16. 
Recsei, P., Kreiswirth, B., O'Reilly, M., Schlievert, P., Gruss, A., & Novick, R.P. (1986). 
Regulation of exoprotein gene expression in Staphylococcus aureus by agr. 
Molecular and General Genetics, 202(1), 58-61. 
Reynolds, P. E., & D. F. J. Brown. (1985). Penicillin-binding proteins of beta-lactam 
resistant strains of Staphylococcus aureus. FEBS Letters, 192, 28-32. 
Rice, K., Peralta, R., Bast, D., de Azavedo, J., & McGavin, M.J. (2001). Description of 
staphylococcus serine protease (ssp) operon in Staphylococcus aureus and 
nonpolar inactivation of sspA-encoded serine protease. Infection and Immunity, 
69, 159-169.  
 113 
 
 
Rice, K.C., Mann, E.E., Endres, J.L. Weiss, E.C., Cassat, J.E., Smeltzer, M.S., & Bayles, 
K.W. (2007). The cidA murein hydrolase regulator contributes to DNA release 
and biofilm development in Staphylococcus aureus, Proceedings of the National 
Academy of Sciences of the United States of America, 104, 8113–8118. 
Robinson, D.A., Kearns, A.M., Holmes, A., Morrison, D., Grundmann, H., Edwards, G., 
O’Brien, F.G., . . . Enright, M.C.(2005). Re-emergence of early pandemic 
Staphylococcus aureus as a community-acquired meticillin-resistant clone. 
Lancet, 365, 1256-1258. 
Roghmann, M., Taylor, K.L., Gupte, A., Zhan, M., Johnson, J.A., Cross, A., Edelman, R., 
& Fattom, A.I., (2005). Epidemiology of capsular and surface polysaccharide in 
Staphylococcus aureus infections complicated by bacteraemia. Journal of 
Hospital Infections, 59, 27-32. 
Romagnani, S., Giudizi, M.G., Biagiotti, R., Almerigogna, F., Maggi, E., Del Prete, G., & 
Ricci, M. (1981). Surface immunoglobulins are involved in the interaction of 
protein A with human B cells and in the triggering of B cell proliferation induced 
by protein A-containing Staphylococcus aureus. Journal of Immunology, 127, 
1307-1313. 
Rooijakkers, S. H., van Wamel, W. J., Ruyken, M., van Kessel, K. P., & van Strijp, J. A. 
(2005a). Anti-opsonic properties of staphylokinase. Microbes and Infection, 7, 
476-484. 
Rooijakkers, S.H.M., Ruyken, M., Roos, A., Daha, M.R., Presanis, J.S., Sim, R.B., van 
Wamel, W.J., van Kessel, K.P., & van Strijp, J.A. (2005b). Immune evasion by a 
staphylococcal complement inhibitor that acts on C3 convertases. Nature 
Immunology, 6, 920-927. 
 114 
 
 
Rooijakkers, S. H., Van Kessel, K. P., & Van Strijp, J. A. (2005c). Staphylococcal innate 
immune evasion. Trends in Microbiology, 13, 596-601. 
Rosenbach, A.J. (1884). Mikro-Qrganismen bei den Wund-Infections-Krankheiten des 
Menschen. Wiesbaden, Germany: J.F. Bergmann, p. 18. 
Salgado, C.D., Farr, B.M., & Calfee, D.P. (2003). Community-acquired methicillin-
resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. 
Clinical Infectious Diseases, 36, 131-139. 
Sambanthamoorthy, K., Smeltzer, M.S., & Elasri, M.O. (2006). Identification and 
characterization of msa (SA1233), a gene involved in expression of SarA and 
several virulence factors in Staphylococcus aureus. Microbiology, 152, 2559-
2572. 
Sambanthamoorthy K., Schwartz A., Nagarajan V., & Elasri M. O. (2008). The role of 
msa in Staphylococcus aureus biofilm formation. BMC Microbiology, 8, 221. 
Saravia-Otten, P., Muller, H.P., & Arvidson, S. (1997). Transcription of Staphylococcus 
aureus fibronectin binding protein genes is negatively regulated by agr and an 
agr-independent mechanism. Journal of Bacteriology, 179, 5259-5263. 
Saravolatz, L.D., Markowitz, N., Arking, L., Pohlod, D., & Fisher, E. (1982a). 
Methicillin-resistant Staphylococcus aureus. Epidemiologic observations during a 
community-acquired outbreak. Annals of Internal Medicine, 96, 11-16. 
Saravolatz, L.D., Pohlod, D.J., & Arking, L.M. (1982b). Community-acquired 
methicillin-resistant Staphylococcus aureus infections: a new source for 
nosocomial outbreaks. Annals of Internal Medicine, 97, 325-329. 
 115 
 
 
Schwarz-Linek, U., Werner, J.M., Pickford, A.R., Gurusiddapa, S., Kim, J.H., Pilka, E.S., 
Briggs, J.A., . . . Potts, J.R. (2003). Pathogenic bacteria attach to human 
fibronectin through a tandem β-zipper. Nature, 423, 177-181. 
Serruto, D., Spadafina, T., Ciucchi, L., Lewis, L. A., Ram S., Tontini M., Santini L., . . . 
Arico B. (2010). Neisseria meningitidis GNA2132, a heparin-binding protein that 
induces protective immunity in humans. Proceedings of the National Academy of 
Sciences of the United States of America, 107, 3770-3775.  
Shaw, L., Golonka, E., Potempa, J., & Foster, S.J. (2004). The role and regulation of the 
extracellular proteases of Staphylococcus aureus. Microbiology, 150, 217-228. 
Shopsin, B., Gomez, M., Montgomery, S.O., Smith, D.H., Waddington, M., Dodge, D.E., 
Bost, D.A., Riehman, M., Naidich, S., & Kreiswirth, B.N. (1999). Evaluation of 
protein A gene polymorphic region DNA sequencing for typing of 
Staphylococcus aureus strains. Journal of Clinical Microbiology, 37, 3556-3563. 
Shurland, S.M., Johnson, J.K., Venezia, R.A., Stine, O.C., & Roghmann, M. (2007). 
Screening for USA300: Are the anterior nares adequate? K-448. p. 328, 47th 
ICAAC, Chicago, IL Sept. 17–20, 2007. 
Sieprawska-Lupa, M., Mydel, M., Krawczyk, K., Wójcik, K., Puklo, M., Lupa, B., Suder, 
P., Silberring, J., Reed, M., Pohl, J., Shafer, W., McAleese, F., Foster, T., Travis, 
J., & Potempa, J. (2004). Degradation of human antimicrobial peptide LL-37 by 
Staphylococcus aureus derived proteinases. Antimicrobial Agents and 
Chemotherapy, 48, 4673-4679. 
Signas C., Raucci, G., Jonsson, K., Lindgren, P.E., Anantharamaiah, G.M., Hook, M., & 
Lindberg, M. (1989). Nucleotide sequence of the gene for a fibronectin-binding 
protein from Staphylococcus aureus: use of this peptide sequence in the synthesis 
 116 
 
 
of biologically active peptides. Proceedings of the National Academy of Sciences 
of the United States of America, 86, 699-703. 
Smith, C.B., Noble, V., Bensch, P., Ahlin, A., Jacobson, J.A., & Latham, R.H., (1982). 
Bacterial flora of the vagina during the menstrual cycle: findings in users of 
tampons, napkins, and sea sponges. Annals of Internal Medicine, 96, 948-951. 
Tenover, F.C., McDougal, L.K., Goering, R.V., Killgore, G., Projan, S.J., Patel, J.B., & 
Dunman, P.M. (2006). Characterization of a strain of community-associated 
methicillin-resistant Staphylococcus aureus widely disseminated in the United 
States. Journal of Clinical Microbiology, 44(1), 108-118. 
Tenover, F. C., Arbeit, R., Archer, G., Biddle, J., Byrne, S., Goering, R., Hancock, G., . . 
. Hollis, R. (1994). Comparison of traditional and molecular methods of typing 
isolates of Staphylococcus aureus. Journal of Clinical Microbiology, 32, 407-415. 
Thakker, M., Park, J. S., Carey, V. & Lee, J. C. (1998). Staphylococcus aureus serotype 5 
capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a 
murine bacteremia model. Infection and Immunity, 66, 5183-5189. 
Thompson, R.L., Cabezudo, I., & Wenzel, R.P. (1982). Epidemiology of nosocomial 
infections caused by methicillin-resistant Staphylococcus aureus. Annals of 
Internal Medicine, 97, 309-317. 
Timens, W. (1991). The human spleen and the immune system: not just another lymphoid 
organ, Research in Immunology, 142, 316-320. 
Tormo, M.A., Marti, M., Valle, J., Manna, A.C., Cheung, A.L., Lasa, I., & Penades, J.R. 
(2005b). SarA is an essential positive regulator of Staphylococcus epidermidis 
biofilm development. Journal of Bacteriology, 187, 2348-2356. 
 117 
 
 
Tsang, L.H., Cassat, J.E., Shaw, L.N., Beenken, K.E., & Smeltzer, M.S., (2008). Factors 
contributing to the biofilm-deficient phenotype of Staphylococcus aureus sarA 
mutants. PLoS ONE, 3, e3361. 
Udo, E.E., Pearman, J.W., & Grubb, W.B. (1993). Genetic analysis of community 
isolates of methicillin-resistant Staphylococcus aureus in Western Australia. 
Journal of Hospital Infection, 25, 97-108. 
Uhlen, M., Guss, B., Nilsson, B., Gatenbeck, S., Philipson, L., & Lindberg, M. (1984). 
Complete sequence of the staphylococcal gene encoding protein A. A gene 
evolved through multiple duplications. Journal of Biological Chemistry, 259, 
1695-1702. 
Utsui, Y., & T. Yokota. (1985). Role of an altered penicillin-binding protein in 
methicillin- and cephem-resistant Staphylococcus aureus. Antimicrobial Agents 
and Chemotherapy, 28, 397-403. 
van den Dobbelsteen, G.P.J.M., Brunekreef, K., Kroes, H., van Rooijen, N., & van Rees, 
E.P. (1993). Enhanced triggering of mucosal immune responses by reducing 
splenic phagocytic functions, European Journal of Immunology, 23, 1448-1493. 
Vandenesch, F., Kornblum, J., & R. P. Novick (1991). A temporal signal, independent of 
agr, is required for hla but not spa transcription in Staphylococcus aureus. 
Journal of Bacteriology, 173, 6313-6320.  
Vandenesch, F., Naimi, T., Enright, M.C., Lina, G., Nimmo, G.R., Heffernan, H., 
Liassine, N., . . . Etienne, J. (2003). Community-acquired methicillin-resistant 
Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide 
emergence. Emerging Infectious Diseases, 9, 978-984. 
 118 
 
 
van Oss, C.J. (1978). Phagocytosis as a surface phenomenon. Annual Reviews of 
Microbiology, 32, 19-39. 
Van Wamel, W.J.B., Rooijakkers, S.H.M., Ruyken, M., Van Kessel, K.P.M., & Van 
Strijp, J.A.G. (2006). The innate immune modulators staphylococcal complement 
inhibitor and chemotaxis inhibitory protein of Staphylococcus aureus are located 
on β-hemolysin-converting bacteriophages. Journal of Bacteriology, 188, 1310-
1315. 
von Eiff, C.B.K., Machka, K., Stammer, H., & Peters, G. (2001). Nasal carriage as a 
Source of Staphylococcus aureus Bacteremia, Study Group. New England 
Journal of Medicine, 344, 11-16. 
Voyich, J.M., Braughton, K.R., Sturdevant, D.E., Whitney, A.R., Said-Salim, B., 
Porcella, S.F., Long, R.D., . . . DeLeo, F.R. (2005). Insights into mechanisms used 
by Staphylococcus aureus to avoid destruction by human neutrophils. Journal of 
Immunology, 175, 3907-3919. 
Wardenburg, J.B., Bae, T., Otto, M., DeLeo, F.R., & Schneewind, O. (2007). Poring over 
pores: alpha-hemolysin and Panton-Valentine leukocidin in Staphylococcus 
aureus pneumonia. Nature Medicine, 13, 1405-1406. 
Weiss, E.C., Zielinska, A., Beenken, K.E., Spencer, H.J., Daily, S.J., & Smeltzer, MS. 
(2009). Impact of sarA on daptomycin susceptibility of Staphylococcus aureus 
biofilms in vivo. Antimicrobial Agents and Chemotherapy, 53(10), 4096-4102. 
Williams, R.E. (1963). Healthy carriage of Staphylococcus aureus: its prevalence and 
importance. Bacteriological Reviews, 27, 56-71. 
Williams, R. E. (1946). Skin and nose carriage of bacteriophage types of Staphylococcus 
aureus. Journal of Pathology & Bacteriology, 58, 259-268. 
 119 
 
 
Wiseman G M. (1975). The hemolysins of Staphylococcus aureus. Bacteriological 
Reviews, 39, 317-334. 
Wistreich (2011). Staphylococcus aureus. Microbe World. Retrieved from 
http://www.microbeworld.org/component/jlibrary/?view=article&id=7611. 
Wolz, C., McDevitt, D., Foster, T.J., & Cheung, A.L. (1996). Influence of agr on 
fibrinogen binding in Staphylococcus aureus Newman. Infection and Immunity, 
64, 3142-3147. 
Wolz, C., Pohlmann-Dietze, P., Steinhuber, A., Chien, Y.S.T., Manna, A., van Wamel, 
W., & Cheung, A.L. (2000). Agr-independent regulation of fibronectin-binding 
protein(s) by the regulatory locus sar in Staphylococcus aureus. Molecular 
Microbiology, 36, 230-243. 
Xiong, Y.Q., Willard, J., Yeaman, M.R., Cheung, A.L., & Bayer, A.S. (2006). Regulation 
of Staphylococcus aureus α-toxin gene expression by agr, sarA, and sae in vitro 
and in experimental infective endocarditis. Journal of Infectious Diseases, 194, 
1267-75. 
Zetola, N., Francis, J. S., Nuermberger, E. L., & Bishai, W. R. (2005). Community-
acquired meticillin-resistant Staphylococcus aureus: an emerging threat. Lancet 
Infectious Diseases, 5, 275-286. doi: 10.1016/S1473-3099(05)70112-2. 
Zhang, L., Gray, L., Novick, R.P., & Ji, G. (2002). Transmembrane topology of AgrB, 
the protein involved in the post-translational modification of AgrD in 
Staphylococcus aureus. The Journal of Biological Chemistry, 277, 34736-34742. 
Zhang, L., & Ji, G. (2004). Identification of staphylococcal AgrB segment(s) responsible 
for group-specific processing of AgrD by gene swapping. Journal of 
Bacteriology, 186, 6706-6713. 
 120 
 
 
Zhang, L., Lin, J., & Ji, G. (2004). Membrane anchoring of the AgrD N-terminal 
amphipathic region is required for its processing to produce a quorum sensing 
pheromone in Staphylococcus aureus. The Journal of Biological Chemistry, 279, 
19448-19456. 
Zhu, Y., Weiss, E.C., Otto, M., Fey, P.D., Smeltzer, M.S., & Somerville, G.A. (2007). 
Staphylococcus aureus biofilm metabolism and the influence of arginine on 
polysaccharide intercellular adhesin synthesis, biofilm formation, and 
pathogenesis. Infection and Immunity, 75(9), 4219-4226. 
Ziebandt, A.K., Weber, H., Rudolph, J., Schmid, R., Hoper, D., Engelmann, S., & 
Hecker, M. (2001). Extracellular Proteins of Staphylococcus aureus and the role 
of sarA and sigma B. Proteomics, 1, 480-493. 
